Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1999; 60 Suppl 22:7-11.
Evolution of remission as the new standard in the treatment of depression.
Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. J Clin Psychiatry. 2000 Jun; 61(6):403-8.
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
Mischoulon D, McColl-Vuolo R, Howarth S, Lagomasino IT, Alpert JE, Nierenberg AA, Fava M
Management of major depression in the primary care setting. Psychother Psychosom. 2001 Mar-Apr; 70(2):103-7.
Management of major depression in the primary care setting.
Murrough JW, Huryk KM, Mao X, Iacoviello B, Collins K, Nierenberg AA, Kang G, Shungu DC, Iosifescu DV
A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo. J Affect Disord. 2018 04 01; 230:56-64.
A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo.
Nierenberg AA, Ghaznavi SA, Sande Mathias I, Ellard KK, Janos JA, Sylvia LG
Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders. Biol Psychiatry. 2018 05 01; 83(9):761-769.
Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
Petersen T, Papakostas GI, Posternak MA, Kant A, Guyker WM, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M
Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol. 2005 Aug; 25(4):336-41.
Empirical testing of two models for staging antidepressant treatment resistance.
Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006 Mar 23; 354(12):1231-42.
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, Sachs G
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. Psychiatr Serv. 2006 May; 57(5):660-5.
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Ellard KK, Zimmerman JP, Kaur N, Van Dijk KRA, Roffman JL, Nierenberg AA, Dougherty DD, Deckersbach T, Camprodon JA
Biological psychiatry. Cognitive neuroscience and neuroimaging
Functional Connectivity Between Anterior Insula and Key Nodes of Frontoparietal Executive Control and Salience Networks Distinguish Bipolar Depression From Unipolar Depression and Healthy Control Subjects. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 05; 3(5):473-484.
Biol Psychiatry Cogn Neurosci Neuroimaging
Functional Connectivity Between Anterior Insula and Key Nodes of Frontoparietal Executive Control and Salience Networks Distinguish Bipolar Depression From Unipolar Depression and Healthy Control Subjects.
Gold AK, Otto MW, Deckersbach T, Sylvia LG, Nierenberg AA, Kinrys G
Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes. Am J Addict. 2018 04; 27(3):188-201.
Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes.
Declaration of treatment failures. Mod Probl Pharmacopsychiatry. 1997; 25:17-33.
Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997 Dec; 154(12):1760-2.
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
Grush LR, Nierenberg A, Keefe B, Cohen LS
St John's wort during pregnancy. JAMA. 1998 Nov 11; 280(18):1566.
Rauch SL, Kim H, Makris N, Cosgrove GR, Cassem EH, Savage CR, Price BH, Nierenberg AA, Shera D, Baer L, Buchbinder B, Caviness VS, Jenike MA, Kennedy DN
Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurg. 2000 Dec; 93(6):1019-25.
Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study.
World psychiatry : official journal of the World Psychiatric Association (WPA)
A counter proposal to manage financial conflicts of interest in academic psychiatry. World Psychiatry. 2007 Feb; 6(1):34-6.
A counter proposal to manage financial conflicts of interest in academic psychiatry.
Michelson D, Adler LA, Amsterdam JD, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF, Kelsey DK, Williams DW
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Apr; 68(4):582-7.
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
Alpert JE, Petersen T, Roffi PA, Papakostas GI, Freed R, Smith MM, Spector AR, Nierenberg AA, Rosenbaum JF, Fava M
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks. Psychother Psychosom. 2003 Mar-Apr; 72(2):102-6.
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks.
Papakostas GI, Petersen T, Iosifescu DV, Roffi PA, Alpert JE, Rosenbaum JF, Fava M, Nierenberg AA
Axis III disorders in treatment-resistant major depressive disorder. Psychiatry Res. 2003 May 30; 118(2):183-8.
Axis III disorders in treatment-resistant major depressive disorder.
Nierenberg AA, Rapaport MH, Schettler PJ, Howland RH, Smith JA, Edwards D, Schneider T, Mischoulon D
Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V. CNS Neurosci Ther. 2010 Aug; 16(4):208-16.
Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.
Mitochondrial Dysfunction: At the Core of Psychiatric Disorders? Biol Psychiatry. 2018 05 01; 83(9):718-719.
Mitochondrial Dysfunction: At the Core of Psychiatric Disorders?
Sherrill JT, Sommers DI, Nierenberg AA, Leon AC, Arndt S, Bandeen-Roche K, Greenhouse J, Guthrie D, Normand SL, Phillips KA, Shear MK, Woolson R
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
Integrating statistical and clinical research elements in intervention-related grant applications: summary from an NIMH workshop. Acad Psychiatry. 2009 May-Jun; 33(3):221-8.
Integrating statistical and clinical research elements in intervention-related grant applications: summary from an NIMH workshop.
Amsterdam JD, Williams D, Michelson D, Adler LA, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder. Neuropsychobiology. 2009; 59(4):227-33.
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Novak L, Iosifescu DV
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. Clin Trials. 2009 Dec; 6(6):637-48.
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Perlis RH, Ostacher M, Fava M, Nierenberg AA, Sachs GS, Rosenbaum JF
Assuring that double-blind is blind. Am J Psychiatry. 2010 Mar; 167(3):250-2.
Kornstein SG, Young EA, Harvey AT, Wisniewski SR, Barkin JL, Thase ME, Trivedi MH, Nierenberg AA, Rush AJ
The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause. 2010 Jul; 17(4):828-39.
The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women.
Dording CM, Mischoulon D, Goodness TM, Baer L, Clain A, Stewart JW, Matthews JD, McGrath PJ, Nierenberg AA, Fava M, Papakostas GI
Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome. CNS Spectr. 2010 Aug; 15(8):515-21.
Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome.
Dupuy JM, Ostacher MJ, Huffman J, Perlis RH, Nierenberg AA
The international journal of neuropsychopharmacology
A critical review of pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol. 2011 Nov; 14(10):1417-31.
A critical review of pharmacotherapy for major depressive disorder.
Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. J Clin Psychiatry. 2012 Jul; 73(7):967-76.
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, Iosifescu DV
The Australian and New Zealand journal of psychiatry
Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. Aust N Z J Psychiatry. 2013 Jan; 47(1):26-42.
Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development.
Fava M, Targum SD, Nierenberg AA, Bleicher LS, Carter TA, Wedel PC, Hen R, Gage FH, Barlow C
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. J Psychiatr Res. 2012 Dec; 46(12):1553-63.
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery.
Is standard deviation always the right choice? Am J Psychiatry. 1986 Sep; 143(9):1198-9.
Is standard deviation always the right choice?
Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine. Evid Based Ment Health. 2007 Feb; 10(1):12.
Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine.
Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006 Feb; 163(2):217-24.
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Kane JM, Correll CU, Nierenberg AA, Caroff SN, Sajatovic M
Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop. J Clin Psychiatry. 2018 May/Jun; 79(3).
Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop.
Henin A, Biederman J, Mick E, Hirshfeld-Becker DR, Sachs GS, Wu Y, Yan L, Ogutha J, Nierenberg AA
Childhood antecedent disorders to bipolar disorder in adults: a controlled study. J Affect Disord. 2007 Apr; 99(1-3):51-7.
Childhood antecedent disorders to bipolar disorder in adults: a controlled study.
Mirtazapine in the treatment of mood and anxiety disorders. Expert Rev Neurother. 2003 Jul; 3(4):425-33.
Mirtazapine in the treatment of mood and anxiety disorders.
Reimherr F, Amsterdam J, Dunner D, Adler L, Zhang S, Williams D, Marchant B, Michelson D, Nierenberg A, Schatzberg A, Feldman P
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine. Psychiatry Res. 2010 Jan 30; 175(1-2):67-73.
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
Hopes and dreams: healthcare reform and comparative effectiveness research for personalized treatment in psychiatry and neurology. CNS Spectr. 2010 Feb; 15(2):74-5.
Hopes and dreams: healthcare reform and comparative effectiveness research for personalized treatment in psychiatry and neurology.
Petersen T, Hughes M, Papakostas GI, Kant A, Fava M, Rosenbaum JF, Nierenberg AA
Treatment-resistant depression and Axis II comorbidity. Psychother Psychosom. 2002 Sep-Oct; 71(5):269-74.
Treatment-resistant depression and Axis II comorbidity.
Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ
The Psychiatric clinics of North America
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am. 2003 Jun; 26(2):457-94, x.
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry. 2003; 64 Suppl 15:13-7.
Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.
Stange JP, Eisner LR, Hölzel BK, Peckham AD, Dougherty DD, Rauch SL, Nierenberg AA, Lazar S, Deckersbach T
Mindfulness-based cognitive therapy for bipolar disorder: effects on cognitive functioning. J Psychiatr Pract. 2011 Nov; 17(6):410-9.
Mindfulness-based cognitive therapy for bipolar disorder: effects on cognitive functioning.
Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol. 2005 Dec; 8(4):523-8.
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS
Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
Does recovery from substance use disorder matter in patients with bipolar disorder?
What next? A review of pharmacologic strategies for treatment resistant depression. Psychopharmacol Bull. 1990; 26(4):429-60.
What next? A review of pharmacologic strategies for treatment resistant depression.
Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry. 1990 Jun; 51 Suppl:39-47; discussion 48-50.
Treatment-resistant depression: definition and treatment approaches.
Iosifescu DV, Renshaw PF, Dougherty DD, Lyoo IK, Lee HK, Fraguas R, Cassano P, Nierenberg AA, Fava M
The Journal of nervous and mental disease
Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities. J Nerv Ment Dis. 2007 Feb; 195(2):175-8.
Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities.
Iosifescu DV, Bolo NR, Nierenberg AA, Jensen JE, Fava M, Renshaw PF
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry. 2008 Jun 15; 63(12):1127-34.
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, McGrath PJ, Thase ME, Klinkman M, Nierenberg AA, Yates WR, Fava M
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med. 2008 May; 23(5):551-60.
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Spillmann MK, Van der Does AJ, Rankin MA, Vuolo RD, Alpert JE, Nierenberg AA, Rosenbaum JF, Hayden D, Schoenfeld D, Fava M
Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology (Berl). 2001 May; 155(2):123-7.
Tryptophan depletion in SSRI-recovered depressed outpatients.
Petersen T, Papakostas GI, Bottonari K, Iacoviello B, Alpert JE, Fava M, Nierenberg AA
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Res. 2002 Jan 31; 109(1):9-16.
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.
Ellard KK, Gosai AG, Bernstein EE, Kaur N, Sylvia LG, Camprodon JA, Dougherty DD, Nierenberg AA, Deckersbach T
Intrinsic functional neurocircuitry associated with treatment response to transdiagnostic CBT in bipolar disorder with anxiety. J Affect Disord. 2018 10 01; 238:383-391.
Intrinsic functional neurocircuitry associated with treatment response to transdiagnostic CBT in bipolar disorder with anxiety.
Nierenberg AA, Bentley KH, Farabaugh AH, Fava M, Deckersbach T
The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale. Aust N Z J Psychiatry. 2012 Dec; 46(12):1165-72.
The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale.
Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA
Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom. 2013; 82(1):10-9.
Nutrient-based therapies for bipolar disorder: a systematic review.
Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, Ostacher MJ, Leon AC, Reilly-Harrington N, Iosifescu DV, Pencina M, Severe JB, Calabrese JR
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry. 2013 Jan; 170(1):102-10.
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
Phillips KA, Nierenberg AA, Brendel G, Fava M
Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J Nerv Ment Dis. 1996 Feb; 184(2):125-9.
Prevalence and clinical features of body dysmorphic disorder in atypical major depression.
Nelson JC, Docherty JP, Henschen GM, Kasper S, Nierenberg AA, Ward NG
Algorithms for the treatment of subtypes of unipolar major depression. Psychopharmacol Bull. 1995; 31(3):475-82.
Algorithms for the treatment of subtypes of unipolar major depression.
Hodgkin D, Stewart MT, Merrick EL, Pogue YZ, Reilly-Harrington NA, Sylvia LG, Deckersbach T, Nierenberg AA
Prevalence and predictors of physician recommendations for medication adjustment in bipolar disorder treatment. J Affect Disord. 2018 10 01; 238:666-673.
Prevalence and predictors of physician recommendations for medication adjustment in bipolar disorder treatment.
Deckersbach T, Hölzel BK, Eisner LR, Stange JP, Peckham AD, Dougherty DD, Rauch SL, Lazar S, Nierenberg AA
Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder. CNS Neurosci Ther. 2012 Feb; 18(2):133-41.
Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder.
Stepping back to step forward: lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2011 Oct; 72(10):1429-31.
Stepping back to step forward: lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Magalhães PV, Dodd S, Nierenberg AA, Berk M
Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Aust N Z J Psychiatry. 2012 Nov; 46(11):1058-67.
Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry. 2004 Aug; 65(8):1096-8.
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.
Papakostas GI, Petersen T, Denninger JW, Tossani E, Pava JA, Alpert JE, Nierenberg AA, Fava M
Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol. 2004 Oct; 24(5):507-11.
Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov; 163(11):1905-17.
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
Promises, pitfalls, and pleasures of practicing evidence based psychiatry and neurology. CNS Spectr. 2009 Dec; 14(12):665-7.
Promises, pitfalls, and pleasures of practicing evidence based psychiatry and neurology.
Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, Miyahara S, Sachs GS, Perlman C, Ghaemi SN, Thase ME, Otto MW
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. 2006 Mar; 67(3):394-9.
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH
The British journal of psychiatry : the journal of mental science
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
Nierenberg AA, Alpert JE, Gaynes BN, Warden D, Wisniewski SR, Biggs MM, Trivedi MH, Barkin JL, Rush AJ
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. J Affect Disord. 2008 May; 108(1-2):129-34.
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Bystritsky A, Nierenberg AA, Feusner JD, Rabinovich M
Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness. J Psychiatr Res. 2012 Apr; 46(4):428-35.
Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness.
Gold AK, Peters AT, Otto MW, Sylvia LG, Magalhaes PVDS, Berk M, Dougherty DD, Miklowitz DJ, Frank E, Nierenberg AA, Deckersbach T
The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial. Aust N Z J Psychiatry. 2018 09; 52(9):847-855.
The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial.
Sylvia LG, Hearing CM, Montana RE, Gold AK, Walsh SL, Janos JA, Tovey RE, Deckersbach T, Nierenberg AA
MoodNetwork: An Innovative Approach to Patient-centered Research. Med Care. 2018 10; 56 Suppl 10 Suppl 1:S48-S52.
MoodNetwork: An Innovative Approach to Patient-centered Research.
Worthington J, Fava M, Davidson K, Alpert J, Nierenberg AA, Rosenbaum JF
Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacol Bull. 1995; 31(2):223-6.
Patterns of improvement in depressive symptoms with fluoxetine treatment.
El-Mallakh RS, Ghaemi SN, Sagduyu K, Thase ME, Wisniewski SR, Nierenberg AA, Zhang HW, Pardo TA, Sachs G
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. J Affect Disord. 2008 Dec; 111(2-3):372-7.
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.
Howland RH, Schettler PJ, Rapaport MH, Mischoulon D, Schneider T, Fasiczka A, Delrahiem K, Maddux R, Lightfoot M, Nierenberg AA
Clinical features and functioning of patients with minor depression. Psychother Psychosom. 2008; 77(6):384-9.
Clinical features and functioning of patients with minor depression.
Fan J, Ionita-Laza I, McQueen MB, Devlin B, Purcell S, Faraone SV, Allen MH, Bowden CL, Calabrese JR, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TB, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel JK, Sachs GS, Thase ME, Molay FB, Escamilla MA, Nimgaonkar VL, Sklar P, Laird NM, Smoller JW
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 05; 153B(1):29-37.
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010 Jan; 122(1):184-91.
Review of medication adherence in children and adults with ADHD.
Something borrowed, something blue: why is bipolar disorder an orphan? CNS Spectr. 2010 Jan; 15(1):15-6.
Something borrowed, something blue: why is bipolar disorder an orphan?
Antidepressants: can't live with them, can't live without them. CNS Spectr. 2010 Mar; 15(3):146-7.
Antidepressants: can't live with them, can't live without them.
Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. J Clin Psychopharmacol. 2010 Aug; 30(4):357-64.
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
The assessment and treatment of refractory depression. J Clin Psychiatry. 1994 Feb; 55 Suppl:20-6.
The assessment and treatment of refractory depression.
A new era for CNS Spectrums. CNS Spectr. 2009 May; 14(5):232-3.
Are we losing our minds? CNS Spectr. 2010 Jul; 15(7):416-7.
Primary care companion to the Journal of clinical psychiatry
A critical appraisal of treatments for bipolar disorder. Prim Care Companion J Clin Psychiatry. 2010; 12(Suppl 1):23-9.
A critical appraisal of treatments for bipolar disorder.
Yaramala SR, McElroy SL, Geske J, Winham S, Gao K, Reilly-Harrington NA, Ketter TA, Deckersbach T, Kinrys G, Kamali M, Sylvia LG, McInnis MG, Friedman ES, Thase ME, Kocsis JH, Tohen M, Calabrese JR, Bowden CL, Shelton RC, Nierenberg AA, Bobo WV
The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. J Affect Disord. 2020 04 01; 266:772-781.
The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study.
Iovieno N, van Nieuwenhuizen A, Clain A, Baer L, Nierenberg AA
Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. Depress Anxiety. 2011 Feb; 28(2):137-44.
Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M
Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 1994 Jul; 151(7):1069-72.
Trazodone for antidepressant-associated insomnia.
Deckersbach T, Perlis RH, Frankle WG, Gray SM, Grandin L, Dougherty DD, Nierenberg AA, Sachs GS
Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr. 2004 Mar; 9(3):227-31.
Presence of irritability during depressive episodes in bipolar disorder.
Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, Rosenbaum JF, Fava M
Obesity among outpatients with major depressive disorder. Int J Neuropsychopharmacol. 2005 Mar; 8(1):59-63.
Obesity among outpatients with major depressive disorder.
Ostacher MJ, Nierenberg AA, Perlis RH, Eidelman P, Borrelli DJ, Tran TB, Marzilli Ericson G, Weiss RD, Sachs GS
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry. 2006 Dec; 67(12):1907-11.
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. JAMA. 1988 Mar 18; 259(11):1699-702.
How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test.
Major depressive disorder: epidemiology, course of illness, and treatment. CNS Spectr. 2008 May; 13(5 Suppl 8):4-7.
Major depressive disorder: epidemiology, course of illness, and treatment.
Ostacher MJ, Nierenberg AA, Iosifescu DV, Eidelman P, Lund HG, Ametrano RM, Kaczynski R, Calabrese J, Miklowitz DJ, Sachs GS, Perlick DA
Correlates of subjective and objective burden among caregivers of patients with bipolar disorder. Acta Psychiatr Scand. 2008 Jul; 118(1):49-56.
Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
Gardos G, Cole JO, Matthews JD, Nierenberg AA, Dugan SJ
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia. Neuropsychopharmacology. 1992 Jun; 6(4):241-7.
The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia.
Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009 Feb; 166(2):173-81.
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH
Family history of depression and therapeutic outcome: findings from STAR*D. J Clin Psychiatry. 2009 Feb; 70(2):185-95.
Family history of depression and therapeutic outcome: findings from STAR*D.
Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010 Jan; 40(1):41-50.
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Uncertainty and practical reasoning in clinical psychiatry and neurology. CNS Spectr. 2009 Jun; 14(6):284-5.
Uncertainty and practical reasoning in clinical psychiatry and neurology.
Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone SV, Fossey MD, Gyulai L, Loftis JM, Hauser P, Ketter TA, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Laird N, Keshavan M, Thase ME, Axelson D, Birmaher B, Lewis D, Monk T, Frank E, Kupfer DJ, Devlin B, Nimgaonkar VL
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009 Nov; 11(7):701-10.
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
My Mother's Levetiracetam. CNS Spectr. 2010 Aug; 15(8):487-8.
Advancing the treatment of depression with personalized medicine. J Clin Psychiatry. 2012 May; 73(5):e17.
Advancing the treatment of depression with personalized medicine.
Behrendt-Møller I, Madsen T, Sørensen HJ, Sylvia L, Friedman ES, Shelton RC, Bowden CL, Calabrese JR, McElroy SL, Ketter TA, Reilly-Harrington NA, Gao K, Thase M, V Bobo W, Tohen M, McInnis M, Kamali M, Kocsis JH, Deckersbach T, Köhler-Forsberg O, Nierenberg AA
Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder. Bipolar Disord. 2019 06; 21(4):350-360.
Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder.
Nierenberg AA, Feighner JP, Rudolph R, Cole JO, Sullivan J
Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol. 1994 Dec; 14(6):419-23.
Venlafaxine for treatment-resistant unipolar depression.
Baldassano CF, Truman CJ, Nierenberg A, Ghaemi SN, Sachs GS
Akathisia: a review and case report following paroxetine treatment. Compr Psychiatry. 1996 Mar-Apr; 37(2):122-4.
Akathisia: a review and case report following paroxetine treatment.
Kinrys G, Gold AK, Pisano VD, Freeman MP, Papakostas GI, Mischoulon D, Nierenberg AA, Fava M
Tachyphylaxis in major depressive disorder: A review of the current state of research. J Affect Disord. 2019 02 15; 245:488-497.
Tachyphylaxis in major depressive disorder: A review of the current state of research.
Dougherty DD, Baer L, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, Jenike MA, Rauch SL
Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry. 2002 Feb; 159(2):269-75.
Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder.
Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert JE, Rosenbaum JF, Fava M
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry. 2004 Feb; 65(2):217-21.
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
Petersen T, Papakostas GI, Mahal Y, Guyker WM, Beaumont EC, Alpert JE, Fava M, Nierenberg AA
European psychiatry : the journal of the Association of European Psychiatrists
Psychosocial functioning in patients with treatment resistant depression. Eur Psychiatry. 2004 Jun; 19(4):196-201.
Psychosocial functioning in patients with treatment resistant depression.
Henin A, Biederman J, Mick E, Sachs GS, Hirshfeld-Becker DR, Siegel RS, McMurrich S, Grandin L, Nierenberg AA
Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry. 2005 Oct 01; 58(7):554-61.
Psychopathology in the offspring of parents with bipolar disorder: a controlled study.
The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry. 1994 Sep; 55 Suppl A:55-9; discussion 60-1, 98-100.
The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?
Leiter FL, Nierenberg AA, Sanders KM, Stern TA
Discontinuation reactions following sertraline. Biol Psychiatry. 1995 Nov 15; 38(10):694-5.
Discontinuation reactions following sertraline.
Spangler WJ, Cosgrove GR, Ballantine HT, Cassem EH, Rauch SL, Nierenberg A, Price BH
Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery. 1996 Jun; 38(6):1071-6; discussion 1076-8.
Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease.
Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA
The Adult ADHD Quality Measures Initiative. J Atten Disord. 2019 08; 23(10):1063-1078.
The Adult ADHD Quality Measures Initiative.
Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M, Nierenberg AA, Trivedi MH
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry. 2008 Aug; 65(8):870-80.
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry. 2009 Dec; 70(12):1636-44.
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.
Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. J Clin Psychiatry. 2011 Oct; 72(10):1322-32.
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Iosifescu DV, Severe J, Keyes M, Nierenberg AA
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder. Clin Trials. 2012 Feb; 9(1):94-101.
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.
Magalhães PV, Kapczinski F, Nierenberg AA, Deckersbach T, Weisinger D, Dodd S, Berk M
Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand. 2012 Apr; 125(4):303-8.
Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder.
Chan HN, Rush AJ, Nierenberg AA, Trivedi M, Wisniewski SR, Balasubramani GK, Friedman ES, Gaynes BN, Davis L, Morris D, Fava M
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. Int J Neuropsychopharmacol. 2012 Nov; 15(10):1387-99.
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.
Ellard KK, Gosai AK, Felicione JM, Peters AT, Shea CV, Sylvia LG, Nierenberg AA, Widge AS, Dougherty DD, Deckersbach T
Deficits in frontoparietal activation and anterior insula functional connectivity during regulation of cognitive-affective interference in bipolar disorder. Bipolar Disord. 2019 05; 21(3):244-258.
Deficits in frontoparietal activation and anterior insula functional connectivity during regulation of cognitive-affective interference in bipolar disorder.
Nierenberg AA, Rakhilin M, Deckersbach T
Objective smartphone data as a potential diagnostic marker of bipolar disorder. Aust N Z J Psychiatry. 2019 02; 53(2):171-172.
Objective smartphone data as a potential diagnostic marker of bipolar disorder.
McIntyre RS, Calabrese JR, Nierenberg AA, Farahmand K, Yonan C, Siegert S, Burke J
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder. J Affect Disord. 2019 03 01; 246:217-223.
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
Kinrys G, Bowden CL, Nierenberg AA, Hearing CM, Gold AK, Rabideau DJ, Sylvia LG, Gao K, Kamali M, Bobo WV, Tohen M, Deckersbach T, McElroy SL, Ketter TA, Shelton RC, Friedman ES, Calabrese JR, McInnis MG, Kocsis J, Thase ME, Singh V, Reilly-Harrington NA
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. J Affect Disord. 2019 03 01; 246:126-131.
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.
Small numbers, big impact. Harv Rev Psychiatry. 1999 Jul-Aug; 7(2):109-13.
Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry. 2002 Mar; 14(1):33-8.
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.
Murphy JM, Nierenberg AA, Laird NM, Monson RR, Sobol AM, Leighton AH
Incidence of major depression: prediction from subthreshold categories in the Stirling County Study. J Affect Disord. 2002 Apr; 68(2-3):251-9.
Incidence of major depression: prediction from subthreshold categories in the Stirling County Study.
Nierenberg AA, Papakostas GI, Petersen T, Montoya HD, Worthington JJ, Tedlow J, Alpert JE, Fava M
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. J Clin Psychopharmacol. 2003 Feb; 23(1):92-5.
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
Papakostas GI, Petersen T, Worthington JJ, Roffi PA, Alpert JE, Fava M, Nierenberg AA
International clinical psychopharmacology
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed. Int Clin Psychopharmacol. 2003 Sep; 18(5):293-6.
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA
Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry. 2005 Oct; 162(10):1957-60.
Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006 Jan; 163(1):28-40.
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Taylor CT, Hirshfeld-Becker DR, Ostacher MJ, Chow CW, LeBeau RT, Pollack MH, Nierenberg AA, Simon NM
Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord. 2008 Jun; 22(5):868-76.
Anxiety is associated with impulsivity in bipolar disorder.
Köhler-Forsberg O, Gasse C, Petersen L, Nierenberg AA, Mors O, Østergaard SD
Statin treatment and the risk of depression. J Affect Disord. 2019 03 01; 246:706-715.
Statin treatment and the risk of depression.
Huffman JC, Park LT, Welch CA, Nierenberg AA, Januzzi JL, Pomerantz SR
Case records of the Massachusetts General Hospital. Case 14-2008. A 78-year-old man with anergia and anhedonia associated with cardiovascular surgery. N Engl J Med. 2008 May 08; 358(19):2051-9.
Case records of the Massachusetts General Hospital. Case 14-2008. A 78-year-old man with anergia and anhedonia associated with cardiovascular surgery.
Lipkovich I, Mallinckrodt CH, Prakash A, Nierenberg AA
Addressing methodological issues in studying antidepressant onset efficacy using prespecified sensitivity analyses. Psychopharmacol Bull. 2008; 41(2):40-54.
Addressing methodological issues in studying antidepressant onset efficacy using prespecified sensitivity analyses.
The contribution of clinical trials in psychiatry: a basic science of clinical care. CNS Spectr. 2009 Oct; 14(10):528-9.
The contribution of clinical trials in psychiatry: a basic science of clinical care.
Perlis RH, Ostacher MJ, Miklowitz DJ, Hay A, Nierenberg AA, Thase ME, Sachs GS
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J Clin Psychiatry. 2010 Mar; 71(3):296-303.
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
Nierenberg AA, Leon A, Price LH, Shelton RC, Trivedi MH
The current crisis of confidence in antidepressants. J Clin Psychiatry. 2011 Jan; 72(1):27-33.
The current crisis of confidence in antidepressants.
Sylvia LG, Dupuy JM, Ostacher MJ, Cowperthwait CM, Hay AC, Sachs GS, Nierenberg AA, Perlis RH
Journal of psychopharmacology (Oxford, England)
Sleep disturbance in euthymic bipolar patients. J Psychopharmacol. 2012 Aug; 26(8):1108-12.
Sleep disturbance in euthymic bipolar patients.
Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Nierenberg AA, Deckersbach T
Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment. J Clin Psychiatry. 2013 Mar; 74(3):249-55.
Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment.
Irwin KE, Park ER, Fields LE, Corveleyn AE, Greer JA, Perez GK, Callaway CA, Jacobs JM, Nierenberg AA, Temel JS, Ryan DP, Pirl WF
Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer. Oncologist. 2019 07; 24(7):901-910.
Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer.
Fava M, Rappe SM, Pava JA, Nierenberg AA, Alpert JE, Rosenbaum JF
Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose. J Clin Psychiatry. 1995 Feb; 56(2):52-5.
Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine. J Affect Disord. 2019 05 01; 250:35-42.
Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.
Sylvia LG, Pegg SL, Dufour SC, Janos JA, Bernstein EE, Chang WC, Hall NE, Ellard KK, Nierenberg AA, Deckersbach T
Pilot study of a lifestyle intervention for bipolar disorder: Nutrition exercise wellness treatment (NEW Tx). J Affect Disord. 2019 05 01; 250:278-283.
Pilot study of a lifestyle intervention for bipolar disorder: Nutrition exercise wellness treatment (NEW Tx).
Kim TT, Dufour S, Xu C, Cohen ZD, Sylvia L, Deckersbach T, DeRubeis RJ, Nierenberg AA
Predictive modeling for response to lithium and quetiapine in bipolar disorder. Bipolar Disord. 2019 08; 21(5):428-436.
Predictive modeling for response to lithium and quetiapine in bipolar disorder.
Green J, Castle D, Berk M, Hair C, Loughman A, Cryan J, Nierenberg A, Athan E, Jacka F
Faecal microbiota transplants for depression - Who gives a crapsule? Aust N Z J Psychiatry. 2019 08; 53(8):732-734.
Faecal microbiota transplants for depression - Who gives a crapsule?
Cirillo P, Gold AK, Nardi AE, Ornelas AC, Nierenberg AA, Camprodon J, Kinrys G
Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis. Brain Behav. 2019 06; 9(6):e01284.
Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis.
Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check. JAMA Psychiatry. 2019 08 01; 76(8):779-780.
Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check.
Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A
Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis. BMJ Open. 2019 05 19; 9(5):e027574.
Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.
Köhler-Forsberg O, Cusin C, Nierenberg AA
Evolving Issues in the Treatment of Depression. JAMA. 2019 Jun 25; 321(24):2401-2402.
Evolving Issues in the Treatment of Depression.
Edmund N. and Carroll M. Carpenter Professor of Psychiatry
Assistant Professor of Psychiatry, Part-time
Kelly JF, Hoffman L, Vilsaint C, Weiss R, Nierenberg A, Hoeppner B
Peer support for mood disorder: Characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization. J Affect Disord. 2019 08 01; 255:127-135.
Peer support for mood disorder: Characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization.
Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials. Acta Neuropsychiatr. 2019 Aug; 31(4):230-234.
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials.
Fung VC, Overhage LN, Sylvia LG, Reilly-Harrington NA, Kamali M, Gao K, Shelton RC, Ketter TA, Bobo WV, Thase ME, Calabrese JR, Tohen M, Deckersbach T, Nierenberg AA
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors. J Affect Disord. 2019 10 01; 257:17-22.
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.
Canadian journal of psychiatry. Revue canadienne de psychiatrie
Bipolar II Disorder Is NOT a Myth. Can J Psychiatry. 2019 08; 64(8):537-540.
Post RM, Yatham LN, Vieta E, Berk M, Nierenberg AA
Beyond evidence-based treatment of bipolar disorder: Rational pragmatic approaches to management. Bipolar Disord. 2019 11; 21(7):650-659.
Beyond evidence-based treatment of bipolar disorder: Rational pragmatic approaches to management.
Kamali M, Reilly-Harrington NA, Chang WC, McInnis M, McElroy SL, Ketter TA, Shelton RC, Deckersbach T, Tohen M, Kocsis JH, Calabrese JR, Gao K, Thase ME, Bowden CL, Kinrys G, Bobo WV, Brody BD, Sylvia LG, Rabideau DJ, Nierenberg AA
Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. J Affect Disord. 2019 12 01; 259:164-172.
Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship.
Gold AK, Ornelas AC, Cirillo P, Caldieraro MA, Nardi AE, Nierenberg AA, Kinrys G
Clinical applications of transcranial magnetic stimulation in bipolar disorder. Brain Behav. 2019 10; 9(10):e01419.
Clinical applications of transcranial magnetic stimulation in bipolar disorder.
More on the NIMH RDoC initiative. Bipolar Disord. 2020 02; 22(1):11-12.
Sylvia LG, Janos JA, Pegg SL, Dufour SC, Chang WC, Bernstein EE, Davis B, Ellard KK, Deckersbach T, Nierenberg AA
Feasibility and Acceptability of a Lifestyle Intervention For Individuals With Bipolar Disorder. J Psychiatr Pract. 2019 11; 25(6):451-460.
Feasibility and Acceptability of a Lifestyle Intervention For Individuals With Bipolar Disorder.
Testo AA, Felicione JM, Ellard KK, Peters AT, Chou T, Gosai A, Hahn E, Shea C, Sylvia L, Nierenberg AA, Dougherty DD, Deckersbach T
Neural correlates of the ADHD self-report scale. J Affect Disord. 2020 02 15; 263:141-146.
Neural correlates of the ADHD self-report scale.
Costa MH, Kunz M, Nierenberg AA, Deckersbach T, Berk M, Magalhaes PVS
Kim H, Kim Y, Baek JH, Fava M, Mischoulon D, Nierenberg AA, Choi KW, Na EJ, Shin MH, Jeon HJ
Predictive factors of diagnostic conversion from major depressive disorder to bipolar disorder in young adults ages 19-34: A nationwide population study in South Korea. J Affect Disord. 2020 03 15; 265:52-58.
Predictive factors of diagnostic conversion from major depressive disorder to bipolar disorder in young adults ages 19-34: A nationwide population study in South Korea.
Katz D, Petersen T, Amado S, Kuperberg M, Dufour S, Rakhilin M, Hall NE, Kinrys G, Desrosiers A, Deckersbach T, Sylvia L, Nierenberg AA
An evaluation of suicidal risk in bipolar patients with comorbid posttraumatic stress disorder. J Affect Disord. 2020 04 01; 266:49-56.
An evaluation of suicidal risk in bipolar patients with comorbid posttraumatic stress disorder.
Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings. Am J Psychiatry. 2020 08 01; 177(8):706-715.
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.
Köhler-Forsberg O, Sylvia LG, Ruberto VL, Kuperberg M, Shannon AP, Fung V, Overhage L, Calabrese JR, Thase M, Bowden CL, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Iosifescu DV, McElroy S, Ostacher MJ, Nierenberg AA
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. J Affect Disord. 2020 08 01; 273:131-137.
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response.
Gold AK, Sylvia LG, Nierenberg AA, Ostacher MJ
Preliminary findings on topiramate for addressing health behaviors in comorbid bipolar disorder and alcohol use disorder. Psychiatry Res. 2020 07; 289:113037.
Preliminary findings on topiramate for addressing health behaviors in comorbid bipolar disorder and alcohol use disorder.
Scott J, Etain B, Nierenberg A, Bellivier F
A taxonomy of clinical response to mood stabilizers. Bipolar Disord. 2021 02; 23(1):24-32.
A taxonomy of clinical response to mood stabilizers.
Köhler-Forsberg O, Sylvia LG, Fung V, Overhage L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy SL, Shelton RC, Ostacher MJ, Iosifescu DV, Nierenberg AA
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials. Depress Anxiety. 2021 02; 38(2):114-123.
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials.
Köhler-Forsberg O, Gasse C, Hieronymus F, Petersen L, Christensen RH, Nierenberg AA, Østergaard SD
Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder. Bipolar Disord. 2021 06; 23(4):357-367.
Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder.
Fung V, Price M, Nierenberg AA, Hsu J, Newhouse JP, Cook BL
Assessment of Behavioral Health Services Use Among Low-Income Medicare Beneficiaries After Reductions in Coinsurance Fees. JAMA Netw Open. 2020 10 01; 3(10):e2019854.
Assessment of Behavioral Health Services Use Among Low-Income Medicare Beneficiaries After Reductions in Coinsurance Fees.
Baek JH, Kim JS, Nierenberg AA, Jeon HJ, Hong KS
Clinical Correlates of False Positive Assignment in Bipolar Screening Measures Across Psychiatric Diagnoses among Patients without Bipolar Disorder. Psychiatry Investig. 2020 Nov; 17(11):1118-1125.
Clinical Correlates of False Positive Assignment in Bipolar Screening Measures Across Psychiatric Diagnoses among Patients without Bipolar Disorder.
Collaborating With Patients to Make Treatment Decisions Based on Benefits and Risks of Medications Associated With Tardive Dyskinesia. J Clin Psychiatry. 2020 11 03; 81(6).
Collaborating With Patients to Make Treatment Decisions Based on Benefits and Risks of Medications Associated With Tardive Dyskinesia.
How to Evaluate Patients for Tardive Dyskinesia. J Clin Psychiatry. 2020 12 01; 82(1).
How to Evaluate Patients for Tardive Dyskinesia.
Lamon-Fava S, So J, Mischoulon D, Ziegler TR, Dunlop BW, Kinkead B, Schettler PJ, Nierenberg AA, Felger JC, Maddipati KR, Fava M, Rapaport MH
Prostaglandins, leukotrienes, and essential fatty acids
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukot Essent Fatty Acids. 2021 01; 164:102219.
Prostaglandins Leukot Essent Fatty Acids
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation.
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB
Green JE, Davis JA, Berk M, Hair C, Loughman A, Castle D, Athan E, Nierenberg AA, Cryan JF, Jacka F, Marx W
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes. 2020 11 09; 12(1):1-25.
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis.
Goldberg JF, Nierenberg AA, Iosifescu DV
Wrestling With Antidepressant Use in Bipolar Disorder: The Ongoing Debate. J Clin Psychiatry. 2021 01 19; 82(1).
Wrestling With Antidepressant Use in Bipolar Disorder: The Ongoing Debate.
Kunkle S, Yip M, Hunt J, ? W, Udall D, Arean P, Nierenberg A, Naslund JA
Association Between Care Utilization and Anxiety Outcomes in an On-Demand Mental Health System: Retrospective Observational Study. JMIR Form Res. 2021 Jan 26; 5(1):e24662.
Association Between Care Utilization and Anxiety Outcomes in an On-Demand Mental Health System: Retrospective Observational Study.
Kuperberg M, Greenebaum SLA, Nierenberg AA
Current topics in behavioral neurosciences
Targeting Mitochondrial Dysfunction for Bipolar Disorder. Curr Top Behav Neurosci. 2021; 48:61-99.
Targeting Mitochondrial Dysfunction for Bipolar Disorder.
Kuperberg M, Katz D, Greenebaum SLA, George N, Sylvia LG, Kinrys G, Desrosiers A, Nierenberg AA
Psychotic symptoms during bipolar depressive episodes and suicidal ideation. J Affect Disord. 2021 03 01; 282:1241-1246.
Psychotic symptoms during bipolar depressive episodes and suicidal ideation.
Nierenberg AA, Harris MG, Kazdin AE, Puac-Polanco V, Sampson N, Vigo DV, Chiu WT, Ziobrowski HN, Alonso J, Altwaijri Y, Borges G, Bunting B, Caldas-de-Almeida JM, Haro JM, Hu CY, Kiejna A, Lee S, McGrath JJ, Navarro-Mateu F, Posada-Villa J, Scott KM, Stagnaro JC, Viana MC, Kessler RC
Perceived helpfulness of bipolar disorder treatment: Findings from the World Health Organization World Mental Health Surveys. Bipolar Disord. 2021 09; 23(6):565-583.
Perceived helpfulness of bipolar disorder treatment: Findings from the World Health Organization World Mental Health Surveys.
Alemi F, Aljuaid M, Durbha N, Yousefi M, Min H, Sylvia LG, Nierenberg AA
A surrogate measure for patient reported symptom remission in administrative data. BMC Psychiatry. 2021 03 04; 21(1):121.
A surrogate measure for patient reported symptom remission in administrative data.
Sylvia LG, Janos JA, Pegg SL, Montana RE, Gold AK, Bianchi M, Nierenberg AA
Pilot Study of a Brief Sleep Intervention for Suicidal Ideation in Bipolar Disorder. J Psychiatr Pract. 2021 03 05; 27(2):109-114.
Pilot Study of a Brief Sleep Intervention for Suicidal Ideation in Bipolar Disorder.
Evidence-based versus clinical expertise guidelines for Bipolar Disorders. Bipolar Disord. 2021 08; 23(5):509-510.
Evidence-based versus clinical expertise guidelines for Bipolar Disorders.
de Vries YA, Harris MG, Vigo D, Chiu WT, Sampson NA, Al-Hamzawi A, Alonso J, Andrade LH, Benjet C, Bruffaerts R, Bunting B, Caldas de Almeida JM, de Girolamo G, Florescu S, Gureje O, Haro JM, Hu C, Karam EG, Kawakami N, Kovess-Masfety V, Lee S, Moskalewicz J, Navarro-Mateu F, Ojagbemi A, Posada-Villa J, Scott K, Torres Y, Zarkov Z, Nierenberg A, Kessler RC, de Jonge P
Perceived helpfulness of treatment for specific phobia: Findings from the World Mental Health Surveys. J Affect Disord. 2021 06 01; 288:199-209.
Perceived helpfulness of treatment for specific phobia: Findings from the World Mental Health Surveys.
How to Evaluate Patients and Educate Them About Self-Examinations for Tardive Dyskinesia Between Appointments. J Clin Psychiatry. 2021 03 09; 82(1).
How to Evaluate Patients and Educate Them About Self-Examinations for Tardive Dyskinesia Between Appointments.
Carrozzino D, Patierno C, Guidi J, Berrocal Montiel C, Cao J, Charlson ME, Christensen KS, Concato J, De Las Cuevas C, de Leon J, Eöry A, Fleck MP, Furukawa TA, Horwitz RI, Nierenberg AA, Rafanelli C, Wang H, Wise TN, Sonino N, Fava GA
Clinimetric Criteria for Patient-Reported Outcome Measures. Psychother Psychosom. 2021; 90(4):222-232.
Clinimetric Criteria for Patient-Reported Outcome Measures.
Sylvia LG, Faulkner M, Rakhilin M, Amado S, Gold AK, Albury EA, Dinerman JG, Dohse H, Tovey R, Turner JA, Schopfer DW, Pletcher MJ, Nierenberg AA
An online intervention for increasing physical activity in individuals with mood disorders at risk for cardiovascular disease: Design considerations. J Affect Disord. 2021 08 01; 291:102-109.
An online intervention for increasing physical activity in individuals with mood disorders at risk for cardiovascular disease: Design considerations.
Bowden CL, Priesmeyer R, Tohen M, Singh V, Calabrese JR, Ketter T, Nierenberg A, Thase ME, Siegel G, Siegel LH, Mintz J, El-Mallakh RS, McElroy SL, Martinez M
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder. Psychopharmacol Bull. 2021 Mar 16; 51(2):8-19.
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder.
Kamali M, Pegg S, Janos JA, Bobo WV, Brody B, Gao K, Ketter TA, McElroy SL, McInnis MG, Rabideau DJ, Reilly-Harrington NA, Shelton RC, Sylvia LG, Tohen M, Nierenberg A
Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome. J Psychiatr Res. 2021 08; 140:205-213.
Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome.
Walker AJ, Kim Y, Borissiouk I, Rehder R, Dodd S, Morris G, Nierenberg AA, Maes M, Fernandes BS, Dean OM, Williams LJ, Eyre HA, Kim SW, Zoungas S, Carvalho AF, Berk M
Statins: Neurobiological underpinnings and mechanisms in mood disorders. Neurosci Biobehav Rev. 2021 09; 128:693-708.
Statins: Neurobiological underpinnings and mechanisms in mood disorders.
Assistant Professor of Psychology in the Department of Psychiatry
Köhler-Forsberg O, Sloth KH, Sylvia LG, Thase M, Calabrese JR, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy SL, Shelton RC, Iosifescu DV, Ostacher MJ, Nierenberg AA
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response. Psychiatry Res. 2021 11; 305:114194.
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response.
Gold AK, Albury EA, Stromberg A, French NJ, Peters AT, Katz D, Nierenberg AA, Sylvia LG
Cigarette smokers with a mood symptom history enrolled in a physical activity trial. Bipolar Disord. 2021 12; 23(8):842-843.
Cigarette smokers with a mood symptom history enrolled in a physical activity trial.
Kahawage P, Crowe M, Gottlieb J, Swartz HA, Yatham LN, Bullock B, Inder M, Porter R, Nierenberg AA, Meesters Y, Gordjin M, Haarman BCM, Murray G
Adrift in time: the subjective experience of circadian challenge during COVID-19 amongst people with mood disorders. Chronobiol Int. 2022 01; 39(1):57-67.
Adrift in time: the subjective experience of circadian challenge during COVID-19 amongst people with mood disorders.
Callaway CA, Corveleyn AE, Barry MJ, Gorton EI, Nierenberg AA, Irwin KE
Lessons learned: Building a coalition to advance equity in cancer and mental health care. Psychooncology. 2021 12; 30(12):2087-2091.
Lessons learned: Building a coalition to advance equity in cancer and mental health care.
Physical exercise for bipolar disorder: Time for action. Bipolar Disord. 2022 05; 24(3):324-325.
Physical exercise for bipolar disorder: Time for action.
Chou T, Dougherty DD, Nierenberg AA, Deckersbach T
Restoration of default mode network and task positive network anti-correlation associated with mindfulness-based cognitive therapy for bipolar disorder. Psychiatry Res Neuroimaging. 2022 01; 319:111419.
Restoration of default mode network and task positive network anti-correlation associated with mindfulness-based cognitive therapy for bipolar disorder.
Green JE, Berk M, Loughman A, Marx W, Castle D, McGuinness AJ, Cryan JF, Nierenberg AA, Athan E, Hair C, Jacka F
FMT for psychiatric disorders: Following the brown brick road into the future. Bipolar Disord. 2021 11; 23(7):651-655.
FMT for psychiatric disorders: Following the brown brick road into the future.
Hoare E, Collins S, Marx W, Callaly E, Moxham-Smith R, Cuijpers P, Holte A, Nierenberg AA, Reavley N, Christensen H, Reynolds CF, Carvalho AF, Jacka F, Berk M
Universal depression prevention: An umbrella review of meta-analyses. J Psychiatr Res. 2021 12; 144:483-493.
Universal depression prevention: An umbrella review of meta-analyses.
McNally RJ, Robinaugh DJ, Deckersbach T, Sylvia LG, Nierenberg AA
Journal of psychopathology and clinical science
Estimating the symptom structure of bipolar disorder via network analysis: Energy dysregulation as a central symptom. J Psychopathol Clin Sci. 2022 Jan; 131(1):86-97.
Estimating the symptom structure of bipolar disorder via network analysis: Energy dysregulation as a central symptom.
Migó M, Simpson K, Peters A, Ellard KK, Chou T, Nierenberg AA, Dougherty DD, Deckersbach T
Dimensional Affective Processing in BD. Psychiatry Res. 2022 01; 307:114304.
Kuperberg M, Köhler-Forsberg O, Shannon AP, George N, Greenebaum S, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Iosifescu DV, Ostacher MJ, Sylvia LG, McElroy SL, Nierenberg AA
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response. J Affect Disord. 2022 03 01; 300:41-49.
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response.
Ziobrowski HN, Cui R, Ross EL, Liu H, Puac-Polanco V, Turner B, Leung LB, Bossarte RM, Bryant C, Pigeon WR, Oslin DW, Post EP, Zaslavsky AM, Zubizarreta JR, Nierenberg AA, Luedtke A, Kennedy CJ, Kessler RC
Development of a model to predict psychotherapy response for depression among Veterans. Psychol Med. 2023 Jun; 53(8):3591-3600.
Development of a model to predict psychotherapy response for depression among Veterans.
Lee PH, Doyle AE, Li X, Silberstein M, Jung JY, Gollub RL, Nierenberg AA, Liu RT, Kessler RC, Perlis RH, Fava M
Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study. Biol Psychiatry. 2022 08 01; 92(3):236-245.
Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study.
Peters AT, Millett CE, Harder J, Potter J, Fichorova R, Nierenberg AA, Burdick KE
C-reactive protein and affective inhibition in bipolar disorder. J Affect Disord. 2022 06 01; 306:39-46.
C-reactive protein and affective inhibition in bipolar disorder.
Burdick KE, Millett CE, Yocum AK, Altimus CM, Andreassen OA, Aubin V, Belzeaux R, Berk M, Biernacka JM, Blumberg HP, Cleare AJ, Diaz-Byrd C, Dubertret C, Etain B, Eyler LT, Forester BP, Fullerton JM, Frye MA, Gard S, Godin O, Haffen E, Klaus F, Lagerberg TV, Leboyer M, Martinez-Aran A, McElroy S, Mitchell PB, Olie E, Olorunfemi P, Passerieux C, Peters AT, Pham DL, Polosan M, Potter JR, Sajatovic M, Samalin L, Schwan R, Shanahan M, Solé B, Strawbridge R, Stuart AL, Torres I, Ueland T, Vieta E, Williams LJ, Wrobel AL, Yatham LN, Young AH, Nierenberg AA, McInnis MG
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative. Bipolar Disord. 2022 11; 24(7):709-719.
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative.
Köhler-Forsberg O, Rohde C, Nierenberg AA, Østergaard SD
Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder. JAMA Psychiatry. 2022 05 01; 79(5):454-463.
Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder.
Wrobel AL, Köhler-Forsberg O, Sylvia LG, Russell SE, Dean OM, Cotton SM, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis MG, Kocsis JH, Friedman ES, Ketter TA, Shelton RC, Ostacher MJ, Iosifescu DV, Berk M, Turner A, Nierenberg AA
Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder. Acta Psychiatr Scand. 2022 06; 145(6):615-627.
Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.
Köhler-Forsberg O, Sylvia LG, Thase M, Calabrese JR, Tohen M, Bowden CL, McInnis M, Iosifescu DV, Kocsis JH, Friedman ES, Ketter TA, McElroy SL, Shelton RC, Fung V, Ostacher MJ, Nierenberg AA
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes. Aust N Z J Psychiatry. 2023 01; 57(1):93-103.
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes.
Katz D, Miklowitz D, Gaudiano B, Weinstock L, Gold A, Nierenberg A, Sylvia L
Reports of the demise of CBT for bipolar disorder have been greatly exaggerated: a response to Samamé. Bipolar Disord. 2022 08; 24(5):472-473.
Reports of the demise of CBT for bipolar disorder have been greatly exaggerated: a response to Samamé.
McInnis MG, Andreassen OA, Andreazza AC, Alon U, Berk M, Brister T, Burdick KE, Cui D, Frye M, Leboyer M, Mitchell PB, Merikangas K, Nierenberg AA, Nurnberger JI, Pham D, Vieta E, Yatham LN, Young AH
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder. Bipolar Disord. 2022 08; 24(5):499-508.
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder.
Wong KS, Chou T, Peters AT, Ellard KK, Nierenberg AA, Dougherty DD, Deckersbach T
Convergence between behavioral, neural, and self-report measures of cognitive control: The Frontal Systems Behavior Scale in bipolar disorder. J Psychiatr Res. 2022 06; 150:317-323.
Convergence between behavioral, neural, and self-report measures of cognitive control: The Frontal Systems Behavior Scale in bipolar disorder.
Kessler RC, Kazdin AE, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Altwaijri YA, Andrade LH, Benjet C, Bharat C, Borges G, Bruffaerts R, Bunting B, de Almeida JMC, Cardoso G, Chiu WT, Cía A, Ciutan M, Degenhardt L, de Girolamo G, de Jonge P, de Vries YA, Florescu S, Gureje O, Haro JM, Harris MG, Hu C, Karam AN, Karam EG, Karam G, Kawakami N, Kiejna A, Kovess-Masfety V, Lee S, Makanjuola V, McGrath JJ, Medina-Mora ME, Moskalewicz J, Navarro-Mateu F, Nierenberg AA, Nishi D, Ojagbemi A, Oladeji BD, O'Neill S, Posada-Villa J, Puac-Polanco V, Rapsey C, Ruscio AM, Sampson NA, Scott KM, Slade T, Stagnaro JC, Stein DJ, Tachimori H, Ten Have M, Torres Y, Viana MC, Vigo DV, Williams DR, Wojtyniak B, Xavier M, Zarkov Z, Ziobrowski HN
Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys. World Psychiatry. 2022 Jun; 21(2):272-286.
Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys.
Kahawage P, Bullock B, Meyer D, Gottlieb J, Crowe M, Swartz HA, Yatham LN, Inder M, Porter RJ, Nierenberg AA, Meesters Y, Gordijn M, Haarman BCM, Murray G
Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19. Can J Psychiatry. 2022 11; 67(11):831-840.
Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19.
Bossarte RM, Kessler RC, Nierenberg AA, Chattopadhyay A, Cuijpers P, Enrique A, Foxworth PM, Gildea SM, Belnap BH, Haut MW, Law KB, Lewis WD, Liu H, Luedtke AR, Pigeon WR, Rhodes LA, Richards D, Rollman BL, Sampson NA, Stokes CM, Torous J, Webb TD, Zubizarreta JR
The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients. Trials. 2022 Jun 20; 23(1):520.
The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients.
Similon MVM, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M, Meyer-Lindenberg A, Ketter TA, Yatham LN, Goldberg JF, Malhi GS, El-Mallakh R, Licht RW, Young AH, Kapczinski F, Swartz M, Hagin M, Torrent C, Serretti A, Yildiz A, Martínez-Arán A, Strejilevich S, Rybakowski J, Sani G, Grunze H, Vázquez G, Pinto AG, Azorin JM, Nolen W, Sentissi O, López-Jaramillo C, Frey BN, Nierenberg A, Parker G, Bond DJ, Cohen A, Tortorella A, Perugi G, Vieta E, Popovic D
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. Eur Neuropsychopharmacol. 2022 07; 60:91-99.
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.
Stark CM, Susi A, Nierenberg AA, Nylund CM
Association of Early Life Prescriptions for Antibiotics and Acid Suppressants with Childhood Psychotropic Prescriptions. J Pediatr. 2022 07; 246:191-198.e4.
Association of Early Life Prescriptions for Antibiotics and Acid Suppressants with Childhood Psychotropic Prescriptions.
Dunlop BW, Rakofsky JJ, Mischoulon D, Mayberg HS, Kinkead B, Nierenberg AA, Ziegler TR, Fava M, Rapaport MH
The United States index of socioeconomic deprivation for individuals (USiDep). Pers Med Psychiatry. 2022 Mar-Apr; 31-32.
The United States index of socioeconomic deprivation for individuals (USiDep).
Rhee TG, Shim SR, Forester BP, Nierenberg AA, McIntyre RS, Papakostas GI, Krystal JH, Sanacora G, Wilkinson ST
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022 12 01; 79(12):1162-1172.
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
Irwin KE, Callaway CA, Corveleyn AE, Pappano CR, Barry MJ, Tiersma KM, Nelson ZE, Fields LE, Pirl WF, Greer JA, Temel JS, Ryan DP, Nierenberg AA, Park ER
Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancer. Contemp Clin Trials. 2022 12; 123:106975.
Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancer.
Katz D, Kuperberg M, Kamali M, George N, Mroczek D, Bastarache E, Stephan N, Nierenberg AA, Sylvia L
Decreased Psychological Well-Being in Patients With Bipolar Disorder in Remission. J Psychiatr Pract. 2022 11 01; 28(6):445-453.
Decreased Psychological Well-Being in Patients With Bipolar Disorder in Remission.
Rhee TG, Gillissie ES, Nierenberg AA, McIntyre RS
Association of current and remitted bipolar disorders with health-related quality of life: Findings from a nationally representative sample in the US. J Affect Disord. 2023 01 15; 321:33-40.
Association of current and remitted bipolar disorders with health-related quality of life: Findings from a nationally representative sample in the US.
Sylvia LG, Lunn MR, Obedin-Maliver J, McBurney RN, Nowell WB, Nosheny RL, Mularski RA, Long MD, Merkel PA, Pletcher MJ, Tovey RE, Scalchunes C, Sutphen R, Martin AS, Horn EJ, O'Boyle M, Pitch L, Seid M, Redline S, Greenebaum S, George N, French NJ, Faria CM, Puvanich N, Rabideau DJ, Selvaggi CA, Yu C, Faraone SV, Venkatachalam S, McCall D, Terry SF, Deckersbach T, Nierenberg AA
Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial. J Med Internet Res. 2022 09 12; 24(9):e35620.
Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial.
Mischoulon D, Dunlop BW, Kinkead B, Schettler PJ, Lamon-Fava S, Rakofsky JJ, Nierenberg AA, Clain AJ, Mletzko Crowe T, Wong A, Felger JC, Sangermano L, Ziegler TR, Cusin C, Fisher LB, Fava M, Rapaport MH
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial. J Clin Psychiatry. 2022 08 22; 83(5).
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial.
Gold AK, Albury E, Rabideau DJ, Yu C, Katz D, Nierenberg AA, Sylvia LG
The relationship between suicidal thoughts and well-being among individuals with a history of depression and cardiovascular risk. Psychiatry Res Commun. 2022 Aug; 2(3).
The relationship between suicidal thoughts and well-being among individuals with a history of depression and cardiovascular risk.
Sylvia LG, Gold AK, Rakhilin M, Amado S, Modrow MF, Albury EA, George N, Peters AT, Selvaggi CA, Horick N, Rabideau DJ, Dohse H, Tovey RE, Turner JA, Schopfer DW, Pletcher MJ, Katz D, Deckersbach T, Nierenberg AA
Healthy hearts healthy minds: A randomized trial of online interventions to improve physical activity. J Psychosom Res. 2023 01; 164:111110.
Healthy hearts healthy minds: A randomized trial of online interventions to improve physical activity.
Pogue YZ, Lavelle TA, Hodgkin D, Sylvia L, Ritter G, Nierenberg A
The journal of mental health policy and economics
Psychometric Performance of the SF-6D Quality of Life Measure in an Outpatient Population with Bipolar Disorder. J Ment Health Policy Econ. 2022 Dec 01; 25(4):143-150.
Psychometric Performance of the SF-6D Quality of Life Measure in an Outpatient Population with Bipolar Disorder.
Ghaznavi S, Chou T, Dougherty DD, Nierenberg AA
Differential patterns of default mode network activity associated with negative and positive rumination in bipolar disorder. J Affect Disord. 2023 02 15; 323:607-616.
Differential patterns of default mode network activity associated with negative and positive rumination in bipolar disorder.
Fung V, Price M, McDowell A, Nierenberg AA, Hsu J, Newhouse JP, Cook BL
Coverage Parity And Racial And Ethnic Disparities In Mental Health And Substance Use Care Among Medicare Beneficiaries. Health Aff (Millwood). 2023 01; 42(1):83-93.
Coverage Parity And Racial And Ethnic Disparities In Mental Health And Substance Use Care Among Medicare Beneficiaries.
Green JE, McGuinness AJ, Berk M, Castle D, Athan E, Hair C, Strandwitz P, Loughman A, Nierenberg AA, Cryan JF, Mohebbi M, Jacka F
Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2023 Jan 09; 9(1):5.
Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial.
Green JE, Berk M, Mohebbi M, Loughman A, McGuinness AJ, Castle D, Chatterton ML, Perez J, Strandwitz P, Athan E, Hair C, Nierenberg AA, Cryan JF, Jacka F
Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial. Can J Psychiatry. 2023 05; 68(5):315-326.
Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
Bossarte RM, Ross EL, Liu H, Turner B, Bryant C, Zainal NH, Puac-Polanco V, Ziobrowski HN, Cui R, Cipriani A, Furukawa TA, Leung LB, Joormann J, Nierenberg AA, Oslin DW, Pigeon WR, Post EP, Zaslavsky AM, Zubizarreta JR, Luedtke A, Kennedy CJ, Kessler RC
Development of a model to predict combined antidepressant medication and psychotherapy treatment response for depression among veterans. J Affect Disord. 2023 04 01; 326:111-119.
Development of a model to predict combined antidepressant medication and psychotherapy treatment response for depression among veterans.
Rohde C, Köhler-Forsberg O, Nierenberg AA, Østergaard SD
Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients. Bipolar Disord. 2023 06; 25(4):323-334.
Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients.
Ishtiak-Ahmed K, Köhler-Forsberg O, Mortensen EL, Nierenberg AA, Gasse C
Trends, Patterns and Associated User Characteristics of Antidepressant Prescriptions in Older Adults: A Nationwide Descriptive Cohort Study in Denmark. Drugs Aging. 2023 04; 40(4):355-368.
Trends, Patterns and Associated User Characteristics of Antidepressant Prescriptions in Older Adults: A Nationwide Descriptive Cohort Study in Denmark.
Sylvia LG, Tovey RE, Katz D, Boccagno C, Stromberg AR, Peters AT, Temes CM, Gold AK, Mow J, Puvanich N, Albury EA, Stephan NJ, Faria CM, Nierenberg AA, Kamali MP
A New Treatment Program: Focused Integrated Team-based Treatment Program for Bipolar Disorder (FITT-BD). J Psychiatr Pract. 2023 05 01; 29(3):176-188.
A New Treatment Program: Focused Integrated Team-based Treatment Program for Bipolar Disorder (FITT-BD).
Rohde C, He W, Meigs JB, Levine-Janach MS, Köhler-Forsberg O, Østergaard SD, Nierenberg AA
The risk of diabetes mellitus across mood-stabilizing drugs: A study of 38,693 patients with bipolar disorder. Aust N Z J Psychiatry. 2023 09; 57(9):1292-1295.
The risk of diabetes mellitus across mood-stabilizing drugs: A study of 38,693 patients with bipolar disorder.
Wiuff AC, Rohde C, Jensen BD, Nierenberg AA, Østergaard SD, Köhler-Forsberg O
Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder. Bipolar Disord. 2024 Feb; 26(1):71-83.
Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder.
Concurrent use of polypharmacy and potentially inappropriate medications with antidepressants in older adults: A nationwide descriptive study in Denmark during 2015-2019. Gen Hosp Psychiatry. 2023 May-Jun; 82:66-74.
Concurrent use of polypharmacy and potentially inappropriate medications with antidepressants in older adults: A nationwide descriptive study in Denmark during 2015-2019.
Singh B, Yocum AK, Strawbridge R, Burdick KE, Millett CE, Peters AT, Sperry SH, Fico G, Vieta E, Verdolini N, Godin O, Leboyer M, Etain B, Tso IF, Coombes BJ, McInnis MG, Nierenberg AA, Young AH, Ashton MM, Berk M, Williams LJ, Keramatian K, Yatham LN, Overs BJ, Fullerton JM, Roberts G, Mitchell PB, Andreassen OA, Andreazza AC, Zandi PP, Pham D, Biernacka JM, Frye MA
Patterns of pharmacotherapy for bipolar disorder: A GBC survey. Bipolar Disord. 2024 Feb; 26(1):22-32.
Patterns of pharmacotherapy for bipolar disorder: A GBC survey.
Nierenberg AA, Margolis P, Strakowski S, Trivedi M, Yatham LN
A Bipolar Learning Health Network: An innovation whose time has come. Bipolar Disord. 2023 05; 25(3):177-180.
A Bipolar Learning Health Network: An innovation whose time has come.
Puac-Polanco V, Ziobrowski HN, Ross EL, Liu H, Turner B, Cui R, Leung LB, Bossarte RM, Bryant C, Joormann J, Nierenberg AA, Oslin DW, Pigeon WR, Post EP, Zainal NH, Zaslavsky AM, Zubizarreta JR, Luedtke A, Kennedy CJ, Cipriani A, Furukawa TA, Kessler RC
Development of a model to predict antidepressant treatment response for depression among Veterans. Psychol Med. 2023 08; 53(11):5001-5011.
Development of a model to predict antidepressant treatment response for depression among Veterans.
Chou T, Dougherty DD, Nierenberg AA, Ghaznavi S
Rumination in bipolar disorder associated with brain network and behavioural measures of inhibitory executive control. Acta Neuropsychiatr. 2024 Feb; 36(1):39-43.
Rumination in bipolar disorder associated with brain network and behavioural measures of inhibitory executive control.
Nierenberg A, Lavin P, Javitt DC, Shelton R, Sapko MT, Mathew S, Besthof RE, Javitt JC
International journal of bipolar disorders
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial. Int J Bipolar Disord. 2023 Aug 13; 11(1):28.
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial.
McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, Nierenberg AA, Rosenblat JD, Sanacora G, Schatzberg AF, Shelton R, Stahl SM, Trivedi MH, Vieta E, Vinberg M, Williams N, Young AH, Maj M
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023 Oct; 22(3):394-412.
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
Katz D, Petersen T, Rabideau DJ, Stark A, Pintro K, Alvarez-Hernandez A, Stancroff N, Deng Y, Albury E, Kuperberg M, George N, Amado S, Temes C, Nierenberg AA, Sylvia L
A trial of prolonged exposure therapy for outpatients with comorbid bipolar disorder and posttraumatic stress disorder (PTSD). J Affect Disord. 2024 01 01; 344:432-439.
A trial of prolonged exposure therapy for outpatients with comorbid bipolar disorder and posttraumatic stress disorder (PTSD).
Nierenberg AA, Agustini B, Köhler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M
Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023 10 10; 330(14):1370-1380.
Diagnosis and Treatment of Bipolar Disorder: A Review.
Ishtiak-Ahmed K, Musliner KL, Christensen KS, Mortensen EL, Nierenberg AA, Gasse C
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark. Am J Psychiatry. 2024 Jan 01; 181(1):47-56.
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
Rhee TG, Shim SR, Manning KJ, Tennen HA, Kaster TS, d'Andrea G, Forester BP, Nierenberg AA, McIntyre RS, Steffens DC
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychother Psychosom. 2024; 93(1):8-23.
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression.
Hoekstra RHA, Epskamp S, Nierenberg AA, Borsboom D, McNally RJ
Testing similarity in longitudinal networks: The Individual Network Invariance Test. Psychol Methods. 2024 Apr 11.
Testing similarity in longitudinal networks: The Individual Network Invariance Test.
The main aim of this project is to bring together at least 5,000 patients with mood disorders who will be willing and able to participate in prospective comparative effectiveness studies and provide longitudinal data through their electronic medical record and patient-recorded outcomes.
Mood Patient-Powered Research Network (PPRN)
Predictors of Functional Impairment in Bipolar Disorder: Results From 13 Cohorts From Seven Countries by the Global Bipolar Cohort Collaborative. Focus (Am Psychiatr Publ). 2023 Oct; 21(4):444-452.
Rhee TG, Bommersbach TJ, Rosenheck RA, Nierenberg AA, McIntyre RS
National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States. J Affect Disord. 2024 08 01; 358:342-349.
National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States.
The aggregation of marginal gains: a pragmatic philosophy of clinical care in psychiatry. World Psychiatry. 2024 Jun; 23(2):291-292.
The aggregation of marginal gains: a pragmatic philosophy of clinical care in psychiatry.
Ishtiak-Ahmed K, Christensen KS, Mortensen EL, Nierenberg AA, Gasse C
Sociodemographics and clinical factors associated with depression treatment outcomes in 65,741 first-time users of selective serotonin reuptake inhibitors: A Danish cohort study in older adults. J Affect Disord. 2024 Dec 15; 367:244-254.
Sociodemographics and clinical factors associated with depression treatment outcomes in 65,741 first-time users of selective serotonin reuptake inhibitors: A Danish cohort study in older adults.
Sylvia LG, Hay A, Ostacher MJ, Miklowitz DJ, Nierenberg AA, Thase ME, Sachs GS, Deckersbach T, Perlis RH
Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder. J Clin Psychopharmacol. 2013 Jun; 33(3):343-50.
Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder.
Stange JP, Sylvia LG, Magalhães PV, Frank E, Otto MW, Miklowitz DJ, Berk M, Nierenberg AA, Deckersbach T
Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder. J Psychiatr Res. 2013 Oct; 47(10):1329-36.
Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder.
Response to Carlson letter. Am J Psychiatry. 2013 May; 170(5):559-60.
Trivedi MH, Morris DW, Wisniewski SR, Lesser I, Nierenberg AA, Daly E, Kurian BT, Gaynes BN, Balasubramani GK, Rush AJ
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry. 2013 Jun; 170(6):633-41.
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Ebert MH, Findling RL, Gelenberg AJ, Kane JM, Nierenberg AA, Tariot PN
The effects of the Affordable Care Act on the practice of psychiatry. J Clin Psychiatry. 2013 Apr; 74(4):357-61; quiz 362.
The effects of the Affordable Care Act on the practice of psychiatry.
Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg A, Dow WH, Hui R, Frank R, Newhouse JP, Hsu J
Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs. Med Care. 2013 Jul; 51(7):614-21.
Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.
Kessler RC, Calabrese JR, Farley PA, Gruber MJ, Jewell MA, Katon W, Keck PE, Nierenberg AA, Sampson NA, Shear MK, Shillington AC, Stein MB, Thase ME, Wittchen HU
Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med. 2013 Aug; 43(8):1625-37.
Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders.
Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. J Clin Psychiatry. 2013 Jul; 74(7):e636-41.
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
Gold AK, Rabideau DJ, Nolte D, Faria CM, Deng SY, George N, Boccagno C, Temes CM, Kamali M, Akpolat N, Nierenberg AA, Sylvia LG
Does baseline psychiatric symptom severity predict well-being improvement in low-intensity mindfulness interventions? Psychiatry Res Commun. 2024 Sep; 4(3).
Does baseline psychiatric symptom severity predict well-being improvement in low-intensity mindfulness interventions?
Wrobel AL, Turner M, Dean OM, Berk M, Sylvia LG, Thase ME, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Shelton RC, Ostacher MJ, Iosifescu DV, McElroy SL, Turner A, Nierenberg AA
Understanding the relationship between childhood abuse and affective symptoms in bipolar disorder: New insights from a network analysis. Psychiatry Res. 2024 Dec; 342:116197.
Understanding the relationship between childhood abuse and affective symptoms in bipolar disorder: New insights from a network analysis.
Gold AK, Rabideau DJ, Katz D, Peters AT, Bist J, Albury EA, George N, Hsu IR, Faulkner M, Pletcher MJ, Nierenberg AA, Sylvia LG
Self-Efficacy for Exercise in Adults with Lifetime Depression and Low Physical Activity. Psychiatry Res Commun. 2024 Mar; 4(1).
Self-Efficacy for Exercise in Adults with Lifetime Depression and Low Physical Activity.
Krystal A, Blier P, Culpepper L, Nierenberg AA, Takaesu Y, Kubota N, Moline M, Malhotra M, Pinner K, Yardley J
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms. Neuropsychopharmacol Rep. 2025 Mar; 45(1):e12509.
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium. J Clin Psychopharmacol. 2025 Mar-Apr 01; 45(2):65-66.
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium.
Green JE, Wrobel A, Todd E, Marx W, Berk M, Lotfaliany M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S
Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2025 Mar; 226(3):171-183.
Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis.
Baek JH, Grewal SS, Karam KA, Hanlon ER, Abohashem S, Seligowski AV, Henry M, Osborne MT, Nierenberg AA, Tawakol A
Neurobiological Mechanisms Link Bipolar Disorder to Cardiovascular Disease: A Retrospective Biobank Study of Adverse Event Risk and Contributory Mechanisms. Bipolar Disord. 2025 Feb; 27(1):57-66.
Neurobiological Mechanisms Link Bipolar Disorder to Cardiovascular Disease: A Retrospective Biobank Study of Adverse Event Risk and Contributory Mechanisms.
Smoking and suicidality in subjects with major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Affect Disord. 2013 Sep 25; 150(3):1158-66.
Smoking and suicidality in subjects with major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Reilly-Harrington NA, Sylvia LG, Leon AC, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Ostacher MJ, Iosifescu DV, Rabideau DJ, Thase ME, Nierenberg AA
The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. J Psychiatr Res. 2013 Nov; 47(11):1686-93.
The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research.
Sylvia LG, Friedman ES, Kocsis JH, Bernstein EE, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Bobo WV, Kamali M, McInnis MG, Tohen M, Bowden CL, Ketter TA, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington NA, Singh V, Rabideau DJ, Nierenberg AA
Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. J Affect Disord. 2013 Nov; 151(2):722-727.
Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.
Smoking and suicidality in subjects with bipolar disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Depress Anxiety. 2013 Oct; 30(10):982-90.
Smoking and suicidality in subjects with bipolar disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Russell SE, Wrobel AL, Skvarc DR, Lotfaliany M, Dean OM, Ashton MM, Magalhães PVS, Nierenberg A, Berk M, Turner A
Pharmacotherapy in Comorbid Bipolar Disorder and Post-Traumatic Stress Disorder From the STEP-BD Cohort. Bipolar Disord. 2025 Mar; 27(2):108-118.
Pharmacotherapy in Comorbid Bipolar Disorder and Post-Traumatic Stress Disorder From the STEP-BD Cohort.
Sarris J, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D
Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. J Clin Psychopharmacol. 2013 Dec; 33(6):827-30.
Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder.
Sylvia LG, Iosifescu D, Friedman ES, Bernstein EE, Bowden CL, Ketter TA, Reilly-Harrington NA, Leon AC, Calabrese JR, Ostacher MJ, Rabideau DJ, Thase ME, Nierenberg AA
Use of treatment services in a comparative effectiveness study of bipolar disorder. Psychiatr Serv. 2013 Nov 01; 64(11):1119-26.
Use of treatment services in a comparative effectiveness study of bipolar disorder.
One-carbon metabolism and bipolar disorder. Aust N Z J Psychiatry. 2013 Nov; 47(11):1013-8.
One-carbon metabolism and bipolar disorder.
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62.
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Köhler-Forsberg O, Wiuff AC, Devantier TA, Østergaard SD, Faraone SV, Nierenberg AA
Estimating the 12-Hour Serum Lithium Level (eLi12): Development and Two Proof-of-Concept Studies. J Clin Psychiatry. 2025 Mar 03; 86(1).
Estimating the 12-Hour Serum Lithium Level (eLi12): Development and Two Proof-of-Concept Studies.
Del Tredici AL, Johnson HL, DeHart B, Gutin A, Morin P, Kasten CR, Becker L, Johansen Taber K, Chawla D, Nierenberg AA
Real-World Impact of Pharmacogenomic Testing on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder. J Clin Psychopharmacol. 2025 Jul-Aug 01; 45(4):320-328.
Real-World Impact of Pharmacogenomic Testing on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder.
Katz D, Petersen T, Rabideau DJ, Stark A, Pintro K, Hernandez AA, Montinola SG, Temes C, Nierenberg AA, Sylvia L
Preliminary efficacy of prolonged exposure therapy to reduce suicide risk in co-occurring bipolar disorder & trauma symptoms. J Affect Disord. 2025 Aug 01; 382:55-58.
Preliminary efficacy of prolonged exposure therapy to reduce suicide risk in co-occurring bipolar disorder & trauma symptoms.
Friedman ES, Calabrese JR, Ketter TA, Leon AC, Thase ME, Bowden CL, Sylvia LG, Ostracher MJ, Severe J, Iosifescu DV, Nierenberg AA, Reilly-Harrington NA
Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials. J Affect Disord. 2014 Jan; 152-154:97-104.
Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.
Kemp DE, Sylvia LG, Calabrese JR, Nierenberg AA, Thase ME, Reilly-Harrington NA, Ostacher MJ, Leon AC, Ketter TA, Friedman ES, Bowden CL, Rabideau DJ, Pencina M, Iosifescu DV
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand. 2014 Jan; 129(1):24-34.
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.
Lithium tremor revisited: pathophysiology and treatment. Acta Psychiatr Scand. 2014 Jan; 129(1):17-23.
Lithium tremor revisited: pathophysiology and treatment.
The affordable care act and practice in psychiatry. J Clin Psychiatry. 2013 Nov; 74(11):e23.
The affordable care act and practice in psychiatry.
Strategies for achieving full remission when first-line antidepressants are not enough. J Clin Psychiatry. 2013 Dec; 74(12):e26.
Strategies for achieving full remission when first-line antidepressants are not enough.
Deckersbach T, Peters AT, Sylvia L, Urdahl A, Magalhães PV, Otto MW, Frank E, Miklowitz DJ, Berk M, Kinrys G, Nierenberg A
Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. Am J Psychiatry. 2014 Feb; 171(2):178-86.
Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD.
Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Shesler LW, McElroy SL, Friedman ES, Thase ME, Shelton RC, Bowden CL, Tohen M, Singh V, Deckersbach T, Ketter TA, Kocsis JH, McInnis MG, Schoenfeld D, Bobo WV, Calabrese JR
Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials. 2014 Feb; 11(1):114-27.
Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Beech RD, Leffert JJ, Lin A, Sylvia LG, Umlauf S, Mane S, Zhao H, Bowden C, Calabrese JR, Friedman ES, Ketter TA, Iosifescu DV, Reilly-Harrington NA, Ostacher M, Thase ME, Nierenberg A
Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). Pharmacogenomics J. 2014 Apr; 14(2):182-91.
Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).
Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA
Medication adherence in a comparative effectiveness trial for bipolar disorder. Acta Psychiatr Scand. 2014 May; 129(5):359-65.
Medication adherence in a comparative effectiveness trial for bipolar disorder.
Peters AT, Peckham AD, Stange JP, Sylvia LG, Hansen NS, Salcedo S, Rauch SL, Nierenberg AA, Dougherty DD, Deckersbach T
Correlates of real world executive dysfunction in bipolar I disorder. J Psychiatr Res. 2014 Jun; 53:87-93.
Correlates of real world executive dysfunction in bipolar I disorder.
Norms for performance in the workplace in healthy people: data from the national comorbidity survey replication study. CNS Spectr. 2011 Jul; 16(7):143-52.
Norms for performance in the workplace in healthy people: data from the national comorbidity survey replication study.
Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, Lee D, Jeon HJ
Progress in neuro-psychopharmacology & biological psychiatry
Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 03; 51:113-8.
Prog Neuropsychopharmacol Biol Psychiatry
Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder.
Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Hansen NS, Dougherty DD, Nierenberg AA, Deckersbach T
Extreme attributions predict suicidal ideation and suicide attempts in bipolar disorder: prospective data from STEP-BD. World Psychiatry. 2014 Feb; 13(1):95-6.
Extreme attributions predict suicidal ideation and suicide attempts in bipolar disorder: prospective data from STEP-BD.
Bobo WV, Reilly-Harrington NA, Ketter TA, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, McInnis MG, Friedman ES, Singh V, Tohen M, Bowden CL, Deckersbach T, Calabrese JR, Thase ME, Nierenberg AA, Rabideau DJ, Schoenfeld DA, Faraone SV, Kamali M
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. J Affect Disord. 2014 Jun; 161:30-5.
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Citrome L, Karagianis J, Maguire GA, Nierenberg AA
International journal of clinical practice
Pharmaism: a tale of two perspectives. Int J Clin Pract. 2014 Jun; 68(6):659-61.
Reply: To PMID 23834617. Acta Psychiatr Scand. 2014 Jul; 130(1):73.
O'Hearn B, Akpolat N, Kobaissi H, Kamali M, Nierenberg AA, Sylvia LG, Gold AK
Psychosocial and Psychopharmacological Interventions for Comorbid Bipolar Disorder and Substance Use Disorders: A Review. Psychiatr Ann. 2024 Sep; 54(9):e258-e262.
Psychosocial and Psychopharmacological Interventions for Comorbid Bipolar Disorder and Substance Use Disorders: A Review.
Mind the gap between natural phenomena and human constructs in psychiatric diagnostic frameworks. Asian J Psychiatr. 2025 Sep; 111:104662.
Mind the gap between natural phenomena and human constructs in psychiatric diagnostic frameworks.
Soliman MA, Khafif T, Sylvia L, Nierenberg AA
Bipolar Disorder: An Update on Neurobiology and Treatment. Am J Psychiatry. 2026 Mar 01; 183(3):159-168.
Bipolar Disorder: An Update on Neurobiology and Treatment.
Jacobsen SL, Kraft CL, Nierenberg AA, Devantier TA, Köhler-Forsberg O
Do Patients Comply With 12-h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real-World Clinical Setting. Bipolar Disord. 2025 Nov; 27(7):519-526.
Do Patients Comply With 12-h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real-World Clinical Setting.
Goldberg JF, McIntyre RS, Swartz HA, Freeman MP, Mago R, Citrome L, Rosenblat JD, Thase ME, Tohen M, Vieta E, Malhi GS, Sajatovic M, Shelton RC, Macaluso M, Berk M, Perlis RH, Ostacher MJ, Khan A, Iosifescu DV, Sanacora G, Rubio JM, Kane JM, Goodman DW, Nierenberg AA, Correll CU, Kupka R, Kasper S, Furukawa TA, Davis L, Aaronson ST, Gitlin MJ, Jha MK, Cohen LJ, Papakostas GI, Mitchell PB, Gorwood P, Gupta S, Frye MA, Young AH, Zohar J, Steingard S, Zarate CA, Clayton AH
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force. JAMA Netw Open. 2026 Feb 02; 9(2):e260043.
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.
Wrobel AL, Dean OM, Lotfaliany M, Berk M, Sylvia LG, Thase ME, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Shelton RC, McElroy SL, Turner A, Nierenberg AA
Potential Impact of Childhood Abuse on Quality of Life During Mood-Stabilising Treatment in Individuals Living With Bipolar Disorder. Bipolar Disord. 2026 Mar; 28(2):e70079.
Potential Impact of Childhood Abuse on Quality of Life During Mood-Stabilising Treatment in Individuals Living With Bipolar Disorder.
Green JE, Wrobel A, Todd E, Marx W, Berk M, Lotfalian M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S
Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis: commentary, Green et al. Br J Psychiatry. 2025 Jul; 227(1):511-512.
Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis: commentary, Green et al.
Pandina G, DelBello MP, Rassnick S, Solanki B, Canuso CM, Fristad MA, Correll CU, Nurnberger JI, Singh MK, McInnis MG, Atkinson S, Stedman M, Goes FS, Strakowski SM, Greer TL, Nierenberg AA, Salvadore G, Drevets WC
Clinical outcomes of youth at familial risk for bipolar disorder: A 2-year longitudinal, observational study. J Affect Disord. 2026 Jan 15; 393(Pt B):120492.
Clinical outcomes of youth at familial risk for bipolar disorder: A 2-year longitudinal, observational study.
Cotton SM, Hasty M, Mitchell P, Murray G, Hickie IB, McGorry PD, Walder K, Dean OM, Mihalopoulos C, Yung AR, Van Rheenen TE, Nierenberg AA, Scott J, Williams LJ, Berk L, Davey CG, Crouse JJ, Scott E, Iorfino F, Filia K, Chatterton ML, Macneil C, Perich T, Morton E, Ratheesh A, Berk M
Addressing the unmet needs of bipolar disorder in Australia and beyond. Aust N Z J Psychiatry. 2025 Nov; 59(11):957-965.
Addressing the unmet needs of bipolar disorder in Australia and beyond.
Turner A, Kuperberg M, McGovern H, Wrobel A, Dean OM, Berk M, Sylvia L, McElroy SL, Tohen M, Shelton RC, Iosifescu DV, Thase ME, Kocsis JH, Ostacher MJ, Deckersbach T, McInnis MG, Köhler-Forsberg O, Nierenberg AA
Adverse childhood experiences and cardiometabolic risk factors in people with bipolar disorder. J Affect Disord. 2026 Jan 15; 393(Pt A):120270.
Adverse childhood experiences and cardiometabolic risk factors in people with bipolar disorder.
Freed RD, Tompson MC, Otto MW, Nierenberg AA, Hirshfeld-Becker D, Wang CH, Henin A
Early risk factors for psychopathology in offspring of parents with bipolar disorder: the role of obstetric complications and maternal comorbid anxiety. Depress Anxiety. 2014 Jul; 31(7):583-90.
Early risk factors for psychopathology in offspring of parents with bipolar disorder: the role of obstetric complications and maternal comorbid anxiety.
Epidemiology and course of unipolar mania: results from the national epidemiologic survey on alcohol and related conditions (NESARC). Depress Anxiety. 2014 Sep; 31(9):746-55.
Epidemiology and course of unipolar mania: results from the national epidemiologic survey on alcohol and related conditions (NESARC).
Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder. J Affect Disord. 2014 Dec; 169:144-8.
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.
Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Lee D, Heo JY, Jeon HJ
Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. J Affect Disord. 2014 Dec; 169:112-7.
Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
Wardenaar KJ, van Loo HM, Cai T, Fava M, Gruber MJ, Li J, de Jonge P, Nierenberg AA, Petukhova MV, Rose S, Sampson NA, Schoevers RA, Wilcox MA, Alonso J, Bromet EJ, Bunting B, Florescu SE, Fukao A, Gureje O, Hu C, Huang YQ, Karam AN, Levinson D, Medina Mora ME, Posada-Villa J, Scott KM, Taib NI, Viana MC, Xavier M, Zarkov Z, Kessler RC
The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity. Psychol Med. 2014 Nov; 44(15):3289-302.
The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity.
Calabrese JR, Fava M, Garibaldi G, Grunze H, Krystal AD, Laughren T, Macfadden W, Marin R, Nierenberg AA, Tohen M
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. J Affect Disord. 2014 Oct; 168:439-51.
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
Depression: addressing partial response after first-line antidepressant treatment. J Clin Psychiatry. 2014 Sep; 75(9):978-80.
Depression: addressing partial response after first-line antidepressant treatment.
Peters A, Sylvia LG, Magalhães PV, Miklowitz DJ, Frank E, Otto MW, Hansen NS, Dougherty DD, Berk M, Nierenberg AA, Deckersbach T
Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Psychol Med. 2014 Dec; 44(16):3455-67.
Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study. J Clin Psychopharmacol. 2015 Feb; 35(1):68-74.
Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study.
Mischoulon D, Nierenberg AA, Schettler PJ, Kinkead BL, Fehling K, Martinson MA, Hyman Rapaport M
A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J Clin Psychiatry. 2015 Jan; 76(1):54-61.
A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression.
Bernstein EE, Nierenberg AA, Deckersbach T, Sylvia LG
Eating behavior and obesity in bipolar disorder. Aust N Z J Psychiatry. 2015 Jun; 49(6):566-72.
Eating behavior and obesity in bipolar disorder.
Sylvia LG, Shelton RC, Kemp DE, Bernstein EE, Friedman ES, Brody BD, McElroy SL, Singh V, Tohen M, Bowden CL, Ketter TA, Deckersbach T, Thase ME, Reilly-Harrington NA, Nierenberg AA, Rabideau DJ, Kinrys G, Kocsis JH, Bobo WV, Kamali M, McInnis MG, Calabrese JR
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord. 2015 Mar; 17(2):212-23.
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
Neurotic depression as the missing link: old wine with a new twist on anxiety and major depressive disorder. Epidemiol Psychiatr Sci. 2015 Jun; 24(3):230-2.
Neurotic depression as the missing link: old wine with a new twist on anxiety and major depressive disorder.
Sylvia LG, Thase ME, Reilly-Harrington NA, Salcedo S, Brody B, Kinrys G, Kemp D, Shelton RC, McElroy SL, Kocsis JH, Bobo WV, Kamali M, McInnis M, Friedman E, Tohen M, Bowden CL, Ketter TA, Singh V, Calabrese J, Nierenberg AA, Rabideau DJ, Elson CM, Deckersbach T
Psychotherapy use in bipolar disorder: Association with functioning and illness severity. Aust N Z J Psychiatry. 2015 May; 49(5):453-61.
Psychotherapy use in bipolar disorder: Association with functioning and illness severity.
Nierenberg AA, Østergaard SD, Iovieno N, Walker RS, Fava M, Papakostas GI
Predictors of placebo response in bipolar depression. Int Clin Psychopharmacol. 2015 Mar; 30(2):59-66.
Predictors of placebo response in bipolar depression.
Freed RD, Tompson MC, Wang CH, Otto MW, Hirshfeld-Becker DR, Nierenberg AA, Henin A
Journal of family psychology : JFP : journal of the Division of Family Psychology of the American Psychological Association (Division 43)
Family functioning in the context of parental bipolar disorder: associations with offspring age, sex, and psychopathology. J Fam Psychol. 2015 Feb; 29(1):108-18.
Family functioning in the context of parental bipolar disorder: associations with offspring age, sex, and psychopathology.
Sylvia LG, Salcedo S, Bernstein EE, Baek JH, Nierenberg AA, Deckersbach T
Nutrition, Exercise, and Wellness Treatment in bipolar disorder: proof of concept for a consolidated intervention. Int J Bipolar Disord. 2013 Oct 01; 1(1):24.
Nutrition, Exercise, and Wellness Treatment in bipolar disorder: proof of concept for a consolidated intervention.
Improving outcomes in patients with bipolar depression: a comprehensive review. J Clin Psychiatry. 2015 Mar; 76(3):e10.
Improving outcomes in patients with bipolar depression: a comprehensive review.
Nierenberg AA, Sylvia L, Doederlein A, Edgman-Levitan S, Muskin A, Jewell L, Walker M, Goodman D, Farahbakhsh M, Hearing C, Tovey R, Deckersbach T
Improving the care of patients who have treatment-resistant depression: the promise of the PCORnet Mood Network. J Clin Psychiatry. 2015 Apr; 76(4):e528-30.
Improving the care of patients who have treatment-resistant depression: the promise of the PCORnet Mood Network.
Gonzalez Arnold J, Salcedo S, Ketter TA, Calabrese JR, Rabideau DJ, Nierenberg AA, Bazan M, Leon AC, Friedman ES, Iosifescu D, Sylvia LG, Ostacher M, Thase M, Reilly-Harrington NA, Bowden CL
An exploratory study of responses to low-dose lithium in African Americans and Hispanics. J Affect Disord. 2015 Jun 01; 178:224-8.
An exploratory study of responses to low-dose lithium in African Americans and Hispanics.
Three paths to drug discovery in psychiatry. Am J Psychiatry. 2015 May; 172(5):412-4.
Three paths to drug discovery in psychiatry.
Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Aust N Z J Psychiatry. 2014 Aug; 48(8):705-15.
Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder.
Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV
Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry J. 2015; 2015:352979.
Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study.
Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, Roh S, Jeon HJ
Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. J Affect Disord. 2015 Nov 15; 187:183-7.
Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder.
Nierenberg AA, Sylvia LG, Ellard KK, Ghaznavi S, Deckersbach T
What happens now? The importance of naturalistic course after first mania. J Clin Psychiatry. 2015 Sep; 76(9):e1161-3.
What happens now? The importance of naturalistic course after first mania.
Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR). J Psychiatr Res. 2015 Dec; 71:126-33.
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).
Bernstein EE, Rabideau DJ, Gigler ME, Nierenberg AA, Deckersbach T, Sylvia LG
Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health. J Affect Disord. 2016 Jan 01; 189:203-6.
Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health.
Freed RD, Tompson MC, Otto MW, Nierenberg AA, Henin A
A latent class analysis of parental bipolar disorder: Examining associations with offspring psychopathology. Psychiatry Res. 2015 Dec 15; 230(2):314-22.
A latent class analysis of parental bipolar disorder: Examining associations with offspring psychopathology.
Residual symptoms in depression: prevalence and impact. J Clin Psychiatry. 2015 Nov; 76(11):e1480.
Residual symptoms in depression: prevalence and impact.
Nierenberg AA, Hearing CM, Sande Mathias I, Young LT, Sylvia LG
Getting to wellness: The potential of the athletic model of marginal gains for the treatment of bipolar disorder. Aust N Z J Psychiatry. 2015 Dec; 49(12):1207-14.
Getting to wellness: The potential of the athletic model of marginal gains for the treatment of bipolar disorder.
Rapaport MH, Nierenberg AA, Schettler PJ, Kinkead B, Cardoos A, Walker R, Mischoulon D
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry. 2016 Jan; 21(1):71-9.
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.
Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg AA, Newhouse JP, Hsu J
The introduction of generic risperidone in Medicare Part D. Am J Manag Care. 2016 Jan; 22(1):41-8.
The introduction of generic risperidone in Medicare Part D.
Deckersbach T, Nierenberg AA, McInnis MG, Salcedo S, Bernstein EE, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, Bobo WV, Friedman ES, Singh V, Tohen M, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Reilly-Harrington NA, Rabideau DJ, Kinrys G, Kamali M
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. J Clin Psychiatry. 2016 Jan; 77(1):100-8.
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
Nierenberg AA, McElroy SL, Friedman ES, Ketter TA, Shelton RC, Deckersbach T, McInnis MG, Bowden CL, Tohen M, Kocsis JH, Calabrese JR, Kinrys G, Bobo WV, Singh V, Kamali M, Kemp D, Brody B, Reilly-Harrington NA, Sylvia LG, Shesler LW, Bernstein EE, Schoenfeld D, Rabideau DJ, Leon AC, Faraone S, Thase ME
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry. 2016 Jan; 77(1):90-9.
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Iovieno N, Nierenberg AA, Parkin SR, Hyung Kim DJ, Walker RS, Fava M, Papakostas GI
Relationship between placebo response rate and clinical trial outcome in bipolar depression. J Psychiatr Res. 2016 Mar; 74:38-44.
Relationship between placebo response rate and clinical trial outcome in bipolar depression.
Reilly-Harrington NA, Shelton RC, Kamali M, Rabideau DJ, Shesler LW, Trivedi MH, McElroy SL, Sylvia LG, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Bobo WV, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Gold AK, Singh V, Finkelstein DM, Kinrys G, Nierenberg AA
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. J Affect Disord. 2016 Mar 01; 192:212-8.
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.
Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ
A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. Am J Addict. 2016 Mar; 25(2):94-8.
A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.
Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Yim C, Berk M, Dougherty DD, Nierenberg AA, Deckersbach T
Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment. Br J Psychiatry. 2016 Apr; 208(4):352-8.
Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment.
Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, Heo JY, Jeon HJ
Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder. Psychiatry Investig. 2016 May; 13(3):321-6.
Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder.
Stange JP, Kleiman EM, Sylvia LG, Magalhães PV, Berk M, Nierenberg AA, Deckersbach T
SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD. Depress Anxiety. 2016 06; 33(6):464-72.
SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD.
Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, Sylvia LG
Empirically supported psychosocial interventions for bipolar disorder: Current state of the research. J Affect Disord. 2016 Sep 01; 201:203-14.
Empirically supported psychosocial interventions for bipolar disorder: Current state of the research.
Bipolar disorder: multiple pathways to neuroprogression. Acta Psychiatr Scand. 2016 08; 134(2):89-90.
Bipolar disorder: multiple pathways to neuroprogression.
Peters AT, Shesler LW, Sylvia L, da Silva Magalhaes PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Dougherty DD, Nierenberg AA, Deckersbach T
Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression. Aust N Z J Psychiatry. 2016 Jul; 50(7):667-77.
Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression.
Köhler O, Gasse C, Petersen L, Ingstrup KG, Nierenberg AA, Mors O, Østergaard SD
The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study. Am J Psychiatry. 2016 08 01; 173(8):807-15.
The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study.
Deckersbach T, Peters AT, Sylvia LG, Gold AK, da Silva Magalhaes PV, Henry DB, Frank E, Otto MW, Berk M, Dougherty DD, Nierenberg AA, Miklowitz DJ
A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD. J Affect Disord. 2016 Oct; 203:152-157.
A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD.
COURSE OF TREATMENT RESISTANT DEPRESSION
Complex Dynamic Systems in Mood Disorders
Comparative Effectiveness Study for Bipolar Disorder
Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Cai T, Ebert DD, Hwang I, Li J, de Jonge P, Nierenberg AA, Petukhova MV, Rosellini AJ, Sampson NA, Schoevers RA, Wilcox MA, Zaslavsky AM
Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports. Mol Psychiatry. 2016 10; 21(10):1366-71.
Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports.
Rabideau DJ, Nierenberg AA, Sylvia LG, Friedman ES, Bowden CL, Thase ME, Ketter TA, Ostacher MJ, Reilly-Harrington N, Iosifescu DV, Calabrese JR, Leon AC, Schoenfeld DA
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial. Clin Trials. 2014 Aug; 11(4):494-502.
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.
Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA
Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. J Affect Disord. 2016 Nov 15; 205:159-164.
Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.
Sylvia LG, Salcedo S, Bianchi MT, Urdahl A, Nierenberg AA, Deckersbach T
A Novel Home Sleep Monitoring Device and Brief Sleep Intervention for Bipolar Disorder: Feasibility, Tolerability, and Preliminary Effectiveness. Cognit Ther Res. 2014 Feb 01; 38(1):55-61.
A Novel Home Sleep Monitoring Device and Brief Sleep Intervention for Bipolar Disorder: Feasibility, Tolerability, and Preliminary Effectiveness.
Hodgkin D, Merrick EL, O'Brien PL, McGuire TG, Lee S, Deckersbach T, Nierenberg AA
Testing for clinical inertia in medication treatment of bipolar disorder. J Affect Disord. 2016 Nov 15; 205:13-19.
Testing for clinical inertia in medication treatment of bipolar disorder.
Hahn T, Nierenberg AA, Whitfield-Gabrieli S
Predictive analytics in mental health: applications, guidelines, challenges and perspectives. Mol Psychiatry. 2017 01; 22(1):37-43.
Predictive analytics in mental health: applications, guidelines, challenges and perspectives.
Nierenberg AA, Montana R, Kinrys G, Deckersbach T, Dufour S, Baek JH
L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry. J Affect Disord. 2017 Jan 01; 207:429-433.
L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry.
Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Ebert DD, de Jonge P, Nierenberg AA, Rosellini AJ, Sampson NA, Schoevers RA, Wilcox MA, Zaslavsky AM
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder. Epidemiol Psychiatr Sci. 2017 02; 26(1):22-36.
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.
Gold AK, Montana RE, Sylvia LG, Nierenberg AA, Deckersbach T
Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders. Curr Behav Neurosci Rep. 2016 Dec; 3(4):340-349.
Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders.
McElroy SL, Kemp DE, Friedman ES, Reilly-Harrington NA, Sylvia LG, Calabrese JR, Rabideau DJ, Ketter TA, Thase ME, Singh V, Tohen M, Bowden CL, Bernstein EE, Brody BD, Deckersbach T, Kocsis JH, Kinrys G, Bobo WV, Kamali M, McInnis MG, Leon AC, Faraone S, Nierenberg AA, Shelton RC
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand. 2016 Feb; 133(2):144-153.
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.
Köhler-Forsberg O, Sylvia L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy S, Shelton RC, Nierenberg AA
Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder. Depress Anxiety. 2017 03; 34(3):281-290.
Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.
Sylvia LG, Montana RE, Deckersbach T, Thase ME, Tohen M, Reilly-Harrington N, McInnis MG, Kocsis JH, Bowden C, Calabrese J, Gao K, Ketter T, Shelton RC, McElroy SL, Friedman ES, Rabideau DJ, Nierenberg AA
Poor quality of life and functioning in bipolar disorder. Int J Bipolar Disord. 2017 Dec; 5(1):10.
Poor quality of life and functioning in bipolar disorder.
Lafer B, Nierenberg AA, Rosenbaum JF, Fava M
Outpatients with DSM-III-R versus DSM-IV melancholic depression. Compr Psychiatry. 1996 Jan-Feb; 37(1):37-9.
Outpatients with DSM-III-R versus DSM-IV melancholic depression.
Worthington J, Fava M, Agustin C, Alpert J, Nierenberg AA, Pava JA, Rosenbaum JF
Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. Psychosomatics. 1996 Nov-Dec; 37(6):518-22.
Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment.
Fava M, Alpert J, Nierenberg AA, Ghaemi N, O'Sullivan R, Tedlow J, Worthington J, Rosenbaum JF
Fluoxetine treatment of anger attacks: a replication study. Ann Clin Psychiatry. 1996 Mar; 8(1):7-10.
Fluoxetine treatment of anger attacks: a replication study.
Tedlow JR, Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Rosenbaum JF
Are study dropouts different from completers? Biol Psychiatry. 1996 Oct 01; 40(7):668-70.
Are study dropouts different from completers?
Demopulos C, Fava M, McLean NE, Alpert JE, Nierenberg AA, Rosenbaum JF
Hypochondriacal concerns in depressed outpatients. Psychosom Med. 1996 Jul-Aug; 58(4):314-20.
Hypochondriacal concerns in depressed outpatients.
Fava M, Abraham M, Alpert J, Nierenberg AA, Pava JA, Rosenbaum JF
Gender differences in Axis I comorbidity among depressed outpatients. J Affect Disord. 1996 Jun 05; 38(2-3):129-33.
Gender differences in Axis I comorbidity among depressed outpatients.
Alpert JE, Maddocks A, Nierenberg AA, O'Sullivan R, Pava JA, Worthington JJ, Biederman J, Rosenbaum JF, Fava M
Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996 Jun 01; 62(3):213-9.
Attention deficit hyperactivity disorder in childhood among adults with major depression.
Fava M, Alpert JE, Borus JS, Nierenberg AA, Pava JA, Rosenbaum JF
Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry. 1996 Oct; 153(10):1308-12.
Patterns of personality disorder comorbidity in early-onset versus late-onset major depression.
Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ
An open trial of oral sildenafilin antidepressant-induced sexual dysfunction. Psychother Psychosom. 1998; 67(6):328-31.
An open trial of oral sildenafilin antidepressant-induced sexual dysfunction.
Possible trazodone potentiation of fluoxetine: a case series. J Clin Psychiatry. 1992 Mar; 53(3):83-5.
Possible trazodone potentiation of fluoxetine: a case series.
Evidence of early onset of antidepressant effect in randomized controlled trials. J Clin Psychiatry. 2001; 62 Suppl 4:17-23; discussion 37-40.
Evidence of early onset of antidepressant effect in randomized controlled trials.
Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol. 2002 Aug; 22(4):379-87.
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
From clinical observations to clinimetrics: a tribute to Alvan R. Feinstein, MD. Psychother Psychosom. 2004 May-Jun; 73(3):131-96.
From clinical observations to clinimetrics: a tribute to Alvan R. Feinstein, MD.
From clinical observations to clinimetrics: a tribute to Alvan R. Feinstein, MD. Psychother Psychosom. 2004 May-Jun; 73(3):131-3.
Simon NM, Pollack MH, Fischmann D, Perlman CA, Muriel AC, Moore CW, Nierenberg AA, Shear MK
Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005 Sep; 66(9):1105-10.
Complicated grief and its correlates in patients with bipolar disorder.
Mansour HA, Talkowski ME, Wood J, Pless L, Bamne M, Chowdari KV, Allen M, Bowden CL, Calabrese J, El-Mallakh RS, Fagiolini A, Faraone SV, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TA, Loftis JM, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Thase ME, Frank E, Kupfer DJ, Nimgaonkar VL
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter. Ann Med. 2005; 37(8):590-602.
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Papakostas GI, Petersen TJ, Green C, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M, Posternak MA
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic. Ann Clin Psychiatry. 2005 Jul-Sep; 17(3):161-5.
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic.
Price BH, Baral I, Cosgrove GR, Rauch SL, Nierenberg AA, Jenike MA, Cassem EH
Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. J Clin Psychiatry. 2001 Dec; 62(12):925-32.
Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases.
Papakostas GI, Petersen T, Denninger J, Sonawalla SB, Mahal Y, Alpert JE, Nierenberg AA, Fava M
Somatic symptoms in treatment-resistant depression. Psychiatry Res. 2003 May 01; 118(1):39-45.
Somatic symptoms in treatment-resistant depression.
Papakostas GI, Petersen T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, Fava M, Nierenberg AA
Serum cholesterol in treatment-resistant depression. Neuropsychobiology. 2003; 47(3):146-51.
Serum cholesterol in treatment-resistant depression.
Perlis RH, Alpert J, Nierenberg AA, Mischoulon D, Yeung A, Rosenbaum JF, Fava M
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day. Acta Psychiatr Scand. 2003 Dec; 108(6):432-8.
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.
Nierenberg AA, Quitkin FM, Kremer C, Keller MB, Thase ME
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse. Neuropsychopharmacology. 2004 May; 29(5):1012-8.
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists. J Clin Psychiatry. 1991 Sep; 52(9):383-5.
Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists.
Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF
Major depressive subtypes and treatment response. Biol Psychiatry. 1997 Oct 01; 42(7):568-76.
Major depressive subtypes and treatment response.
Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, DeBattista C, Nelson JC, Nierenberg AA, Sackeim HA, Thase ME
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry. 1999 Mar; 60(3):142-56.
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. Aust N Z J Psychiatry. 2017 Apr; 51(4):355-365.
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.
Sylvia LG, Salcedo S, Peters AT, Magalhães PV, Frank E, Miklowitz DJ, Otto MW, Berk M, Nierenberg AA, Deckersbach T
Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder? J Nerv Ment Dis. 2017 Mar; 205(3):196-202.
Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder?
Nierenberg AA, Dougherty D, Rosenbaum JF
Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry. 1998; 59 Suppl 5:60-3; discussion 64.
Dopaminergic agents and stimulants as antidepressant augmentation strategies.
Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Perlis RH, Papakostas GI, Nierenberg AA, Fava M
Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry. 2006 Feb; 188:180-5.
Brain white-matter hyperintensities and treatment outcome in major depressive disorder.
Marangell LB, Suppes T, Ketter TA, Dennehy EB, Zboyan H, Kertz B, Nierenberg A, Calabrese J, Wisniewski SR, Sachs G
Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov; 75(4-5):315-21.
Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
Nierenberg AA, Price LH, Charney DS, Heninger GR
After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression. J Affect Disord. 1990 Mar; 18(3):167-75.
After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression.
Management options for refractory depression. Am J Med. 1996 Dec 30; 101(6A):45S-52S.
Management options for refractory depression.
Caldieraro MA, Vares EA, Souza LH, Spanemberg L, Guerra TA, Wollenhaupt-Aguiar B, Ferrari P, Nierenberg AA, Fleck MP
Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF. Compr Psychiatry. 2017 May; 75:46-52.
Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF.
Place S, Blanch-Hartigan D, Rubin C, Gorrostieta C, Mead C, Kane J, Marx BP, Feast J, Deckersbach T, Pentland AS, Nierenberg A, Azarbayejani A
Behavioral Indicators on a Mobile Sensing Platform Predict Clinically Validated Psychiatric Symptoms of Mood and Anxiety Disorders. J Med Internet Res. 2017 03 16; 19(3):e75.
Behavioral Indicators on a Mobile Sensing Platform Predict Clinically Validated Psychiatric Symptoms of Mood and Anxiety Disorders.
Do some antidepressants work faster than others? J Clin Psychiatry. 2001; 62 Suppl 15:22-5.
Do some antidepressants work faster than others?
Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry. 2001; 62 Suppl 16:5-9.
Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.
Thase ME, Nierenberg AA, Keller MB, Panagides J
Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients. J Clin Psychiatry. 2001 Oct; 62(10):782-8.
Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.
Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ
Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007 Oct; 164(10):1539-46.
Effect of age at onset on the course of major depressive disorder.
Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97.
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Iosifescu DV, Howarth S, Alpert JE, Nierenberg AA, Worthington JJ, Fava M
International journal of psychiatry in medicine
T3 blood levels and treatment outcome in depression. Int J Psychiatry Med. 2001; 31(4):367-73.
T3 blood levels and treatment outcome in depression.
Nierenberg AA, Phillips KA, Petersen TJ, Kelly KE, Alpert JE, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M
Body dysmorphic disorder in outpatients with major depression. J Affect Disord. 2002 May; 69(1-3):141-8.
Body dysmorphic disorder in outpatients with major depression.
Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M
Nortriptyline for treatment-resistant depression. J Clin Psychiatry. 2003 Jan; 64(1):35-9.
Nortriptyline for treatment-resistant depression.
Dougherty DD, Weiss AP, Cosgrove GR, Alpert NM, Cassem EH, Nierenberg AA, Price BH, Mayberg HS, Fischman AJ, Rauch SL
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg. 2003 Dec; 99(6):1010-7.
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression.
Nierenberg AA, Ghaemi SN, Clancy-Colecchi K, Rosenbaum JF, Fava M
Cynicism, hostility, and suicidal ideation in depressed outpatients. J Nerv Ment Dis. 1996 Oct; 184(10):607-10.
Cynicism, hostility, and suicidal ideation in depressed outpatients.
Long-term management of chronic depression. J Clin Psychiatry. 2001; 62 Suppl 6:17-21.
Long-term management of chronic depression.
Petersen T, Bottonari K, Alpert JE, Fava M, Nierenberg AA
Use of the five-factory inventory in characterizing patients with major depressive disorder. Compr Psychiatry. 2001 Nov-Dec; 42(6):488-93.
Use of the five-factory inventory in characterizing patients with major depressive disorder.
Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, Nierenberg A, Quitkin FM, Sackeim HA, Thase ME, Trivedi M
Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry. 2001 Nov 15; 50(10):792-801.
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Caldieraro MA, Sylvia LG, Dufour S, Walsh S, Janos J, Rabideau DJ, Kamali M, McInnis MG, Bobo WV, Friedman ES, Gao K, Tohen M, Reilly-Harrington NA, Ketter TA, Calabrese JR, McElroy SL, Thase ME, Shelton RC, Bowden CL, Kocsis JH, Deckersbach T, Nierenberg AA
Clinical correlates of acute bipolar depressive episode with psychosis. J Affect Disord. 2017 08 01; 217:29-33.
Clinical correlates of acute bipolar depressive episode with psychosis.
Iosifescu DV, Nierenberg AA, Alpert JE, Papakostas GI, Perlis RH, Sonawalla S, Fava M
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics. 2004 Sep-Oct; 45(5):419-25.
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
Antidepressant adverse drug reactions. J Clin Psychiatry. 1991 Jun; 52 Suppl:40-7.
Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5.
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry. 2006 Sep; 163(9):1531-41; quiz 1666.
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
Should you take St. John's Wort? Health News. 1998 Apr 20; 4(5):4-5.
Alpert JE, Mischoulon D, Nierenberg AA, Fava M
Nutrition (Burbank, Los Angeles County, Calif.)
Nutrition and depression: focus on folate. Nutrition. 2000 Jul-Aug; 16(7-8):544-6.
Nutrition and depression: focus on folate.
Depressive breakthrough. Psychiatr Clin North Am. 2000 Dec; 23(4):731-42.
Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG
Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. J Affect Disord. 2017 08 01; 217:183-189.
Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study.
Deckersbach T, Savage CR, Dougherty DD, Bohne A, Loh R, Nierenberg A, Sachs G, Rauch SL
Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder. Bipolar Disord. 2005 Apr; 7(2):166-75.
Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder.
Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, Pollack MH, Ostacher MJ, Yan L, Siegel R, Sachs GS
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73.
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol. 2005 Oct; 25(5):441-7.
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Ochsner KN, Kosslyn SM, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, Rauch SL
Deficits in visual cognition and attention following bilateral anterior cingulotomy. Neuropsychologia. 2001; 39(3):219-30.
Deficits in visual cognition and attention following bilateral anterior cingulotomy.
Tedlow J, Leslie V, Keefe BR, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M
Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks. J Affect Disord. 1999 Jan-Mar; 52(1-3):217-23.
Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks.
Alpert JE, Fava M, Uebelacker LA, Nierenberg AA, Pava JA, Worthington JJ, Rosenbaum JF
Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biol Psychiatry. 1999 Jul 15; 46(2):202-11.
Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder.
Rauch SL, Dougherty DD, Cosgrove GR, Cassem EH, Alpert NM, Price BH, Nierenberg AA, Mayberg HS, Baer L, Jenike MA, Fischman AJ
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry. 2001 Nov 01; 50(9):659-67.
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder.
Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M, Zisook S
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord. 2010 Dec; 127(1-3):10-8.
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA, Gonzalez JM, Singh V, Nierenberg AA, Sachs GS
Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther. 2012 Mar; 18(3):243-9.
Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).
Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Spector AR, Alpert JE, Fava M, Nierenberg AA
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression. Compr Psychiatry. 2003 Jan-Feb; 44(1):44-50.
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry. 2007 Aug; 164(8):1189-97.
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M
A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan; 26(1):177-87.
A survey of prescribing practices in the treatment of depression.
Newman JR, Ewing SE, McColl RD, Borus JS, Nierenberg AA, Pava J, Fava M
Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study. J Affect Disord. 2000 Jan-Mar; 57(1-3):241-7.
Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study.
Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry. 2000 Jun; 45(5):476-81.
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004 May 01; 55(9):875-81.
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry. 2006 Mar 15; 59(6):493-501.
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006 Feb; 163(2):210-6.
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Shock therapy for depression. Health News. 1998 Feb 17; 4(2):3.
Tedlow J, Fava M, Uebelacker L, Nierenberg AA, Alpert JE, Rosenbaum J
Outcome definitions and predictors in depression. Psychother Psychosom. 1998 Jul-Oct; 67(4-5):266-70.
Outcome definitions and predictors in depression.
Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JF, Fava M
Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999 Apr; 60(4):221-5.
Residual symptoms in depressed patients who respond acutely to fluoxetine.
Current perspectives on the diagnosis and treatment of major depressive disorder. Am J Manag Care. 2001 Sep; 7(11 Suppl):S353-66.
Current perspectives on the diagnosis and treatment of major depressive disorder.
Montoya A, Weiss AP, Price BH, Cassem EH, Dougherty DD, Nierenberg AA, Rauch SL, Cosgrove GR
Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease. Neurosurgery. 2002 May; 50(5):1043-9; discussion 1049-52.
Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease.
Hearing CM, Chang WC, Szuhany KL, Deckersbach T, Nierenberg AA, Sylvia LG
Physical Exercise for Treatment of Mood Disorders: A Critical Review. Curr Behav Neurosci Rep. 2016 Dec; 3(4):350-359.
Physical Exercise for Treatment of Mood Disorders: A Critical Review.
Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. Am J Psychiatry. 1999 Oct; 156(10):1638-40.
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
Frankle WG, Perlis RH, Deckersbach T, Grandin LD, Gray SM, Sachs GS, Nierenberg AA
Bipolar depression: relationship between episode length and antidepressant treatment. Psychol Med. 2002 Nov; 32(8):1417-23.
Bipolar depression: relationship between episode length and antidepressant treatment.
Iosifescu DV, Clementi-Craven N, Fraguas R, Papakostas GI, Petersen T, Alpert JE, Nierenberg AA, Fava M
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder. Psychosom Med. 2005 Sep-Oct; 67(5):703-6.
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder.
Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, Rauch SL, Dougherty D
RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010 Oct; 16(5):298-307.
RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms.
Leon AC, Blier P, Culpepper L, Gorman JM, Hirschfeld RM, Nierenberg AA, Roose SP, Rosenbaum JF, Stahl SM, Trivedi MH
An ideal trial to test differential onset of antidepressant effect. J Clin Psychiatry. 2001; 62 Suppl 4:34-6; discussion 37-40.
An ideal trial to test differential onset of antidepressant effect.
Perlis RH, Brown E, Baker RW, Nierenberg AA
Clinical features of bipolar depression versus major depressive disorder in large multicenter trials. Am J Psychiatry. 2006 Feb; 163(2):225-31.
Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.
Tedlow J, Smith M, Neault N, Polania L, Alpert J, Nierenberg A, Fava M
Melancholia and axis II comorbidity. Compr Psychiatry. 2002 Sep-Oct; 43(5):331-5.
Papakostas GI, Petersen T, Pava J, Masson E, Worthington JJ, Alpert JE, Fava M, Nierenberg AA
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome. J Nerv Ment Dis. 2003 Jul; 191(7):444-9.
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome.
Papakostas GI, Petersen TJ, Farabaugh AH, Murakami JL, Pava JA, Alpert JE, Fava M, Nierenberg AA
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder. J Clin Psychiatry. 2003 Nov; 64(11):1357-61.
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder.
Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry. 2005 Aug; 66(8):1038-42.
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
Papakostas GI, Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Alpert JE, Nierenberg AA, Fava M
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II). Psychiatry Res. 2005 Dec 30; 140(3):301-7.
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).
Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Bipolar Disord. 2006 Feb; 8(1):75-80.
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Trivedi MH, Rush AJ, Wisniewski SR, Warden D, McKinney W, Downing M, Berman SR, Farabaugh A, Luther JF, Nierenberg AA, Callan JA, Sackeim HA
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry. 2006 Feb; 67(2):185-95.
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.
'Mood stabilizers' as the royal road to nirvana or a narrow bridge to well-being? Aust N Z J Psychiatry. 2017 09; 51(9):939-940.
'Mood stabilizers' as the royal road to nirvana or a narrow bridge to well-being?
Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D
Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry. 2008 Sep 15; 64(6):455-60.
Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
Eisner L, Eddie D, Harley R, Jacobo M, Nierenberg AA, Deckersbach T
Dialectical Behavior Therapy Group Skills Training for Bipolar Disorder. Behav Ther. 2017 07; 48(4):557-566.
Dialectical Behavior Therapy Group Skills Training for Bipolar Disorder.
Ellard KK, Bernstein EE, Hearing C, Baek JH, Sylvia LG, Nierenberg AA, Barlow DH, Deckersbach T
Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial. J Affect Disord. 2017 09; 219:209-221.
Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial.
Blais MA, Frank RG, Nierenberg AA, Rauch SL
Measuring outcomes makes good sense. Psychiatr Serv. 2009 Jan; 60(1):112.
Effective agents in treating bipolar depression. J Clin Psychiatry. 2008 10 15; 69(10):e29.
Effective agents in treating bipolar depression.
Yeung A, Chan R, Mischoulon D, Sonawalla S, Wong E, Nierenberg AA, Fava M
Prevalence of major depressive disorder among Chinese-Americans in primary care. Gen Hosp Psychiatry. 2004 Jan-Feb; 26(1):24-30.
Prevalence of major depressive disorder among Chinese-Americans in primary care.
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006 Sep; 163(9):1519-30; quiz 1665.
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
Nierenberg AA, Ostacher MJ, Borrelli DJ, Iosifescu DV, Perlis RH, Desrosiers A, Armistead MS, Calkins AW, Sachs GS
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry. 2006; 67 Suppl 11:3-7.
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry.
Simon NM, Zalta AK, Otto MW, Ostacher MJ, Fischmann D, Chow CW, Thompson EH, Stevens JC, Demopulos CM, Nierenberg AA, Pollack MH
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):255-64.
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder.
Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007 Apr 26; 356(17):1711-22.
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
Papakostas GI, Petersen T, Sklarsky KG, Nierenberg AA, Alpert JE, Fava M
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Psychiatry Res. 2007 Jan 15; 149(1-3):195-200.
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
Papakostas GI, Petersen T, Hughes ME, Nierenberg AA, Alpert JE, Fava M
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. Psychiatry Res. 2004 May 30; 126(3):287-90.
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder.
Kobak KA, Kane JM, Thase ME, Nierenberg AA
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol. 2007 Feb; 27(1):1-5.
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?
Nierenberg AA, Alpert JE, Pava J, Rosenbaum JF, Fava M
Course and treatment of atypical depression. J Clin Psychiatry. 1998; 59 Suppl 18:5-9.
Course and treatment of atypical depression.
Murck H, Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Mannel M, Rosenbaum JF
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo. Int J Neuropsychopharmacol. 2005 Jun; 8(2):215-21.
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.
Mood disorders and suicide. J Clin Psychiatry. 2001; 62 Suppl 25:27-30.
Diagnosing and treating patients with symptoms of depression. J Clin Psychiatry. 2009 Mar 09; 70(3):e05.
Diagnosing and treating patients with symptoms of depression.
Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D
The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder. Nord J Psychiatry. 2009; 63(5):420-5.
The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
Deckersbach T, Rauch SL, Buhlmann U, Ostacher MJ, Beucke JC, Nierenberg AA, Sachs G, Dougherty DD
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report. Bipolar Disord. 2008 Dec; 10(8):928-42.
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report.
Assay sensitivity, failed clinical trials, and the conduct of science. Psychother Psychosom. 2002 Sep-Oct; 71(5):241-3.
Assay sensitivity, failed clinical trials, and the conduct of science.
Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression. Psychother Psychosom. 2009; 78(6):391-3.
Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression.
Sylvia LG, Nierenberg AA, Stange JP, Peckham AD, Deckersbach T
Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder. J Psychiatr Pract. 2011 May; 17(3):224-32.
Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder.
Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, Rush AJ, Shelton RC
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. J Affect Disord. 2011 Oct; 133(3):467-76.
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Posternak MA, Baer L, Nierenberg AA, Fava M
Response rates to fluoxetine in subjects who initially show no improvement. J Clin Psychiatry. 2011 Jul; 72(7):949-54.
Response rates to fluoxetine in subjects who initially show no improvement.
Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M
The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry. 2003 Dec; 160(12):2122-7.
The impact of medical comorbidity on acute treatment in major depressive disorder.
Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M
Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004 Jan-Feb; 26(1):13-7.
Quality of life assessments in major depressive disorder: a review of the literature.
Perlis RH, Iosifescu DV, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression. Psychosomatics. 2004 May-Jun; 45(3):224-9.
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.
Nierenberg AA, Trivedi MH, Ritz L, Burroughs D, Greist J, Sackeim H, Kornstein S, Schwartz T, Stegman D, Fava M, Wisniewski SR
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines. J Psychiatr Res. 2004 Nov-Dec; 38(6):583-9.
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines.
Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005 Apr; 66(4):455-68.
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
Methodological problems in treatment resistant depression research. Psychopharmacol Bull. 1990; 26(4):461-4.
Methodological problems in treatment resistant depression research.
McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E
Predictors of relapse in a prospective study of fluoxetine treatment of major depression. Am J Psychiatry. 2006 Sep; 163(9):1542-8.
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Curr Med Res Opin. 2007 Feb; 23(2):401-16.
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007 May; 164(5):739-52.
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
Nierenberg AA, Smoller JW, Eidelman P, Wu YP, Tilley CA
Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology. Psychother Psychosom. 2008; 77(4):201-8.
Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.
Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH
What predicts attrition in second step medication treatments for depression?: a STAR*D Report. Int J Neuropsychopharmacol. 2009 May; 12(4):459-73.
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009 May; 166(5):599-607.
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol. 1989 Feb; 9(1):42-5.
Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
What have we learned about bipolar disorder from STEP-BD and other practical trials? J Clin Psychiatry. 2009 Aug; 70(8):e30.
What have we learned about bipolar disorder from STEP-BD and other practical trials?
Papakostas GI, Petersen TJ, Kinrys G, Burns AM, Worthington JJ, Alpert JE, Fava M, Nierenberg AA
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J Clin Psychiatry. 2005 Oct; 66(10):1326-30.
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
Wolff N, Perlick DA, Kaczynski R, Calabrese J, Nierenberg A, Miklowitz DJ
Modeling costs and burden of informal caregiving for persons with bipolar disorder. J Ment Health Policy Econ. 2006 Jun; 9(2):99-110.
Modeling costs and burden of informal caregiving for persons with bipolar disorder.
Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM
Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 1997 Apr 15; 41(8):837-43.
Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.
Fava M, Rosenbaum JF, Kolsky AR, Alpert JE, Nierenberg AA, Spillmann M, Moore C, Renshaw P, Bottiglieri T, Moroz G, Magni G
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. J Clin Psychopharmacol. 1999 Aug; 19(4):329-35.
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
Cannon B, Mulroy R, Otto MW, Rosenbaum JF, Fava M, Nierenberg AA
Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression. J Affect Disord. 1999 Sep; 55(1):45-9.
Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression.
Fava M, Vuolo RD, Wright EC, Nierenberg AA, Alpert JE, Rosenbaum JF
Fenfluramine challenge in unipolar depression with and without anger attacks. Psychiatry Res. 2000 Apr 24; 94(1):9-18.
Fenfluramine challenge in unipolar depression with and without anger attacks.
Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, John Rush A
Do atypical features affect outcome in depressed outpatients treated with citalopram? Int J Neuropsychopharmacol. 2010 Feb; 13(1):15-30.
Do atypical features affect outcome in depressed outpatients treated with citalopram?
Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009 Jun; 11(4):391-400.
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Keck PE, Vuckovic A, Pope HG, Nierenberg AA, Gribble GW, White K
Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. J Clin Psychopharmacol. 1989 Jun; 9(3):203-6.
Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011 Jul; 168(7):689-701.
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
Ellard KK, Deckersbach T, Sylvia LG, Nierenberg AA, Barlow DH
Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication series. Behav Modif. 2012 Jul; 36(4):482-508.
Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication series.
Andrew C leon. Neuropsychopharmacology. 2012 Dec; 37(13):2890.
Trivedi MH, Morris DW, Wisniewski SR, Nierenberg AA, Gaynes BN, Kurian BT, Warden D, Stegman D, Shores-Wilson K, Rush AJ
Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients. Can J Psychiatry. 2013 Feb; 58(2):113-22.
Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients.
Alternatives to antidepressants in treating acute bipolar depression. J Clin Psychiatry. 2011 Jan; 72(1):e03.
Alternatives to antidepressants in treating acute bipolar depression.
McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, Cook I, Morris D, Warden D, Rush AJ
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011 Apr; 31(2):180-6.
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
The complexity of "mixed" depression: a common clinical presentation. Innov Clin Neurosci. 2011 Jun; 8(6):38-42.
The complexity of "mixed" depression: a common clinical presentation.
Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. J Affect Disord. 2017 12 01; 223:146-152.
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.
Slyepchenko A, Frey BN, Lafer B, Nierenberg AA, Sachs GS, Dias RS
Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study. Acta Psychiatr Scand. 2017 11; 136(5):473-482.
Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.
Katzman MA, Nierenberg AA, Wajsbrot DB, Meier E, Prieto R, Pappadopulos E, Mackell J, Boucher M
Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder. J Clin Psychopharmacol. 2017 Oct; 37(5):555-561.
Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder.
Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. J Affect Disord. 2018 01 01; 225:775-777.
Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189].
Nierenberg AA, Akiskal HS, Angst J, Hirschfeld RM, Merikangas KR, Petukhova M, Kessler RC
Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R). Mol Psychiatry. 2010 Nov; 15(11):1075-87.
Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R).
Exercise treatment for bipolar disorder: potential mechanisms of action mediated through increased neurogenesis and decreased allostatic load. Psychother Psychosom. 2010; 79(2):87-96.
Exercise treatment for bipolar disorder: potential mechanisms of action mediated through increased neurogenesis and decreased allostatic load.
One size fits none? Treatment algorithms and guidelines in psychiatry and neurology. CNS Spectr. 2010 Apr; 15(4):210-1.
One size fits none? Treatment algorithms and guidelines in psychiatry and neurology.
Sylvia LG, Chang WC, Kamali M, Tohen M, Kinrys G, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington N, Bobo WV, Kocsis JH, McInnis MG, Bowden CL, Ketter TA, Friedman ES, Shelton RC, McElroy SL, Gao K, Rabideau DJ, Nierenberg AA
Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. J Affect Disord. 2018 01 01; 225:563-568.
Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.
Predictors of response to antidepressants general principles and clinical implications. Psychiatr Clin North Am. 2003 Jun; 26(2):345-52, viii.
Predictors of response to antidepressants general principles and clinical implications.
Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum JF
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003 Jun 01; 53(11):1028-42.
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M
Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Res. 2003 May 30; 118(2):137-45.
Serum cholesterol and serotonergic function in major depressive disorder.
Papakostas GI, Iosifescu DV, Petersen T, Hamill SK, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder. J Clin Psychopharmacol. 2004 Aug; 24(4):467-9.
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder.
Iosifescu DV, Papakostas GI, Lyoo IK, Lee HK, Renshaw PF, Alpert JE, Nierenberg A, Fava M
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I). Psychiatry Res. 2005 Dec 30; 140(3):291-9.
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I).
Yeung A, Kung WW, Murakami JL, Mischoulon D, Alpert JE, Nierenberg AA, Fava M
Outcomes of recognizing depressed Chinese American patients in primary care. Int J Psychiatry Med. 2005; 35(3):213-24.
Outcomes of recognizing depressed Chinese American patients in primary care.
Denninger JW, Papakostas GI, Mahal Y, Merens W, Alpert JE, Nierenberg AA, Yeung A, Fava M
Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine. Psychosomatics. 2006 Jul-Aug; 47(4):348-52.
Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry. 2007 Apr; 64(4):419-26.
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
An interview with Andrew Nierenberg, MD: insight into the Sequenced Treatment Alternatives to Relieve Depression Study by Norman Sussman. CNS Spectr. 2007 Dec; 12(12):898-901.
An interview with Andrew Nierenberg, MD: insight into the Sequenced Treatment Alternatives to Relieve Depression Study by Norman Sussman.
Major depressive disorder: barriers to treatment. CNS Spectr. 2009 Mar; 14(3 Suppl 5):5-7.
Major depressive disorder: barriers to treatment.
Distress: to treat or not to treat? CNS Spectr. 2009 Jul; 14(7):344-5.
Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol. 2010 Jul; 25(4):189-98.
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, Rosenbaum JF
Anxiety disorders in major depression. Compr Psychiatry. 2000 Mar-Apr; 41(2):97-102.
Yeung A, Neault N, Sonawalla S, Howarth S, Fava M, Nierenberg AA
Screening for major depression in Asian-Americans: a comparison of the Beck and the Chinese Depression Inventory. Acta Psychiatr Scand. 2002 Apr; 105(4):252-7.
Screening for major depression in Asian-Americans: a comparison of the Beck and the Chinese Depression Inventory.
Kornbluh R, Papakostas GI, Petersen T, Neault NB, Nierenberg AA, Rosenbaum JF, Fava M
A survey of prescribing preferences in the treatment of refractory depression: recent trends. Psychopharmacol Bull. 2001; 35(3):150-6.
A survey of prescribing preferences in the treatment of refractory depression: recent trends.
Yeung A, Chang D, Gresham RL, Nierenberg AA, Fava M
Illness beliefs of depressed Chinese American patients in primary care. J Nerv Ment Dis. 2004 Apr; 192(4):324-7.
Illness beliefs of depressed Chinese American patients in primary care.
Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky KG, Alpert JE, Nierenberg AA, Fava M
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. J Clin Psychiatry. 2004 Apr; 65(4):543-6.
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.
Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004 Aug; 65(8):1090-5.
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
Alpert JE, Papakostas G, Mischoulon D, Worthington JJ, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol. 2004 Dec; 24(6):661-4.
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
Simon NM, Otto MW, Fischmann D, Racette S, Nierenberg AA, Pollack MH, Smoller JW
Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005 Jul; 87(1):101-5.
Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states.
Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, Nierenberg AA, Rosenbaum JF, Shores-Wilson K, Balasubramani GK, Biggs MM, Zisook S, Rush AJ
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry. 2005 Aug; 66(8):1002-11.
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.
Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ
Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006 Mar 23; 354(12):1243-52.
Medication augmentation after the failure of SSRIs for depression.
Nierenberg AA, Trivedi MH, Fava M, Biggs MM, Shores-Wilson K, Wisniewski SR, Balasubramani GK, Rush AJ
Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):214-21.
Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA
Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006 Mar; 12(2):71-9.
Self-rated global measure of the frequency, intensity, and burden of side effects.
Yeung A, Howarth S, Chan R, Sonawalla S, Nierenberg AA, Fava M
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care. J Nerv Ment Dis. 2002 Feb; 190(2):94-9.
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care.
Perlis RH, Fava M, Nierenberg AA, Pollack MH, Falk WE, Kienke AS, Rosenbaum JF
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 2002 Mar-Apr; 10(2):109-14.
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice.
Fava M, Farabaugh AH, Sickinger AH, Wright E, Alpert JE, Sonawalla S, Nierenberg AA, Worthington JJ
Personality disorders and depression. Psychol Med. 2002 Aug; 32(6):1049-57.
Papakostas GI, Petersen T, Denninger JW, Montoya HD, Nierenberg AA, Alpert JE, Fava M
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder. Ann Clin Psychiatry. 2003 Sep-Dec; 15(3-4):187-92.
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004 Feb; 25(1):119-42.
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Keck PE, Carter WP, Nierenberg AA, Cooper TB, Potter WZ, Rothschild AJ
Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. J Clin Psychiatry. 1991 Jun; 52(6):250-4.
Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels.
Simon NM, Pollack MH, Ostacher MJ, Zalta AK, Chow CW, Fischmann D, Demopulos CM, Nierenberg AA, Otto MW
Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007 Jan; 97(1-3):91-9.
Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder.
Nierenberg AA, Ostacher MJ, Huffman JC, Ametrano RM, Fava M, Perlis RH
Journal of occupational and environmental medicine
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder. J Occup Environ Med. 2008 Apr; 50(4):428-36.
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder.
McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, Wisniewski SR, Miyahara S, Nierenberg AA, Fava M, Rush AJ
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry. 2008 Dec; 69(12):1847-55.
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
An analysis of the efficacy of treatments for bipolar depression. J Clin Psychiatry. 2008; 69 Suppl 5:4-8.
An analysis of the efficacy of treatments for bipolar depression.
Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH
Income and attrition in the treatment of depression: a STAR*D report. Depress Anxiety. 2009; 26(7):622-33.
Income and attrition in the treatment of depression: a STAR*D report.
Switch or augment? Lessons from STAR*D. Ann Clin Psychiatry. 2010 Nov; 22(4 Suppl 3):S4-8.
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Kurian BT, Gollan JK, Nierenberg AA, Warden D, Gaynes BN, Luther JF, Rush AJ
Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. J Clin Psychiatry. 2011 Jun; 72(6):765-74.
Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.
Cusin C, Hilton GQ, Nierenberg AA, Fava M
Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression. Am J Psychiatry. 2012 Aug; 169(8):868-9.
Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression.
Fava M, Nierenberg AA, Quitkin FM, Zisook S, Pearlstein T, Stone A, Rosenbaum JF
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia. Psychopharmacol Bull. 1997; 33(1):101-3.
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Alpert JE, Uebelacker LA, McLean NE, Nierenberg AA, Pava JA, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychol Med. 1997 May; 27(3):627-33.
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications.
Kristensen M, Nierenberg AA, Østergaard SD
Face and predictive validity of the Clock?19 mouse as an animal model for bipolar disorder: a systematic review. Mol Psychiatry. 2018 01; 23(1):70-80.
Face and predictive validity of the Clock?19 mouse as an animal model for bipolar disorder: a systematic review.
Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54.
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Nierenberg AA, Burt T, Matthews J, Weiss AP
Mania associated with St. John's wort. Biol Psychiatry. 1999 Dec 15; 46(12):1707-8.
Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, Nierenberg AA, Fava M, Wong KK
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008 Mar; 18(3):230-3.
A detailed examination of cytokine abnormalities in Major Depressive Disorder.
Caldieraro MA, Walsh S, Deckersbach T, Bobo WV, Gao K, Ketter TA, Shelton RC, Reilly-Harrington NA, Tohen M, Calabrese JR, Thase ME, Kocsis JH, Sylvia LG, Nierenberg AA
Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression. Aust N Z J Psychiatry. 2018 10; 52(10):994-1002.
Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression.
Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002 Jul-Aug; 36(4):229-36.
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol. 2002 Oct; 22(5):474-80.
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
The long tale of the short arm of the promoter region for the gene that encodes the serotonin uptake protein. CNS Spectr. 2009 Sep; 14(9):462-3.
The long tale of the short arm of the promoter region for the gene that encodes the serotonin uptake protein.
Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
The perfect storm: CNS drug development in trouble. CNS Spectr. 2010 May; 15(5):282-3.
The perfect storm: CNS drug development in trouble.
The Congressional antidepressant hearings: exploring the relationship between medication and veteran suicide. CNS Spectr. 2010 Jun; 15(6):348-9.
The Congressional antidepressant hearings: exploring the relationship between medication and veteran suicide.
Nierenberg AA, Leon AC, Price LH, Shelton RC, Trivedi MH
Crisis of confidence: antidepressant risk versus benefit. J Clin Psychiatry. 2011 Mar; 72(3):e11.
Crisis of confidence: antidepressant risk versus benefit.
Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004 Dec; 161(12):2222-9.
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Perlis RH, Delbello MP, Miyahara S, Wisniewski SR, Sachs GS, Nierenberg AA
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatry. 2005 Oct 01; 58(7):549-53.
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants.
Roberts E, Cipriani A, Geddes JR, Nierenberg AA, Young AH
The evidence for lithium in suicide prevention. Br J Psychiatry. 2017 12; 211(6):396.
The evidence for lithium in suicide prevention.
Hollon SD, Shelton RC, Wisniewski S, Warden D, Biggs MM, Friedman ES, Husain M, Kupfer DJ, Nierenberg AA, Petersen TJ, Shores-Wilson K, Rush AJ
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. J Psychiatr Res. 2006 Feb; 40(1):59-69.
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial.
Eden Evins A, Demopulos C, Yovel I, Culhane M, Ogutha J, Grandin LD, Nierenberg AA, Sachs GS
Inositol augmentation of lithium or valproate for bipolar depression. Bipolar Disord. 2006 Apr; 8(2):168-74.
Inositol augmentation of lithium or valproate for bipolar depression.
Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, John Rush A, Stegman D, Kelley C, Kreiner K, Nierenberg AA, Fava M
Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry. 2006 Apr-Jun; 18(2):91-8.
Clinical and demographic factors associated with DSM-IV melancholic depression.
Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry. 2006 Jul; 163(7):1161-72.
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Tamada RS, Amaral JA, Issler CK, Nierenberg AA, Lafer B
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
Antidepressant treatment-emergent affective switch in bipolar disorder: a prospective case-control study of outcome. Braz J Psychiatry. 2006 Dec; 28(4):297-300.
Antidepressant treatment-emergent affective switch in bipolar disorder: a prospective case-control study of outcome.
A critical overview of the pharmacologic management of treatment-resistant depression. Psychiatr Clin North Am. 2007 Mar; 30(1):13-29.
A critical overview of the pharmacologic management of treatment-resistant depression.
Lessons from STEP-BD for the treatment of bipolar depression. Depress Anxiety. 2009; 26(2):106-9.
Lessons from STEP-BD for the treatment of bipolar depression.
Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. J Clin Psychiatry. 2008 Aug; 69(8):1246-56.
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
Köhler-Forsberg O, Sylvia L, Deckersbach T, Ostacher MJ, McInnis M, Iosifescu D, Bowden C, McElroy S, Calabrese J, Thase M, Shelton RC, Tohen M, Kocsis J, Friedman E, Ketter T, Nierenberg AA
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder. Acta Neuropsychiatr. 2018 Oct; 30(5):297-305.
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.
Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depress Anxiety. 2009; 26(7):612-21.
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Iosifescu DV, Moore CM, Deckersbach T, Tilley CA, Ostacher MJ, Sachs GS, Nierenberg AA
Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. CNS Neurosci Ther. 2009; 15(4):309-19.
Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.
Failure to integrate brain and mind (or blaming Descartes to understand a very modern dilemma about explanatory models, psychiatric treatment, and underfunding of clinical care and research). CNS Spectr. 2009 Nov; 14(11):599-600.
Failure to integrate brain and mind (or blaming Descartes to understand a very modern dilemma about explanatory models, psychiatric treatment, and underfunding of clinical care and research).
Daly EJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Gaynes BN, Warden D, Morris DW, Luther JF, Farabaugh A, Cook I, Rush AJ
Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry. 2010 Feb; 22(1):43-55.
Health-related quality of life in depression: a STAR*D report.
Rapaport MH, Nierenberg AA, Howland R, Dording C, Schettler PJ, Mischoulon D
The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. J Psychiatr Res. 2011 Jul; 45(7):931-41.
The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.
Marcus SM, Kerber KB, Rush AJ, Wisniewski SR, Nierenberg A, Balasubramani GK, Ritz L, Kornstein S, Young EA, Trivedi MH
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr Psychiatry. 2008 May-Jun; 49(3):238-46.
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study.
Autoinduction of hypertensive reactions by tranylcypromine? J Clin Psychopharmacol. 1989 Feb; 9(1):48-51.
Autoinduction of hypertensive reactions by tranylcypromine?
Ostacher MJ, Lebeau RT, Perlis RH, Nierenberg AA, Lund HG, Moshier SJ, Sachs GS, Simon NM
Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord. 2009 Nov; 11(7):766-71.
Cigarette smoking is associated with suicidality in bipolar disorder.
Perlis RH, Ostacher MJ, Miklowitz DJ, Smoller JW, Dennehy EB, Cowperthwait C, Nierenberg AA, Thase ME, Sachs GS
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. J Clin Psychiatry. 2010 Feb; 71(2):194-200.
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
Revisiting the Clinical Utility of Cytochrome p450 in Practice. Psychiatry (Edgmont). 2007 Nov; 4(11):28-30.
Revisiting the Clinical Utility of Cytochrome p450 in Practice.
Dias RS, Lafer B, Russo C, Del Debbio A, Nierenberg AA, Sachs GS, Joffe H
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry. 2011 Apr; 168(4):386-94.
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD.
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Gollan JK, Warden D, Nierenberg AA, Gaynes BN, Husain MM, Luther JF, Zisook S, Rush AJ
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry. 2011 Jun; 72(6):757-64.
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.
Keck PE, Pope HG, Cohen BM, McElroy SL, Nierenberg AA
Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry. 1989 Oct; 46(10):914-8.
Risk factors for neuroleptic malignant syndrome. A case-control study.
Kinrys G, Gold AK, Worthington JJ, Nierenberg AA
The Journal of international medical research
Medication disposal practices: Increasing patient and clinician education on safe methods. J Int Med Res. 2018 Mar; 46(3):927-939.
Medication disposal practices: Increasing patient and clinician education on safe methods.
Caldieraro MA, Dufour S, Sylvia LG, Gao K, Ketter TA, Bobo WV, Walsh S, Janos J, Tohen M, Reilly-Harrington NA, McElroy SL, Shelton RC, Bowden CL, Deckersbach T, Nierenberg AA
Treatment outcomes of acute bipolar depressive episode with psychosis. Depress Anxiety. 2018 05; 35(5):402-410.
Treatment outcomes of acute bipolar depressive episode with psychosis.
Uebelacker L, Dufour SC, Dinerman JG, Walsh SL, Hearing C, Gillette LT, Deckersbach T, Nierenberg AA, Weinstock L, Sylvia LG
Examining the Feasibility and Acceptability of an Online Yoga Class for Mood Disorders: A MoodNetwork Study. J Psychiatr Pract. 2018 01; 24(1):60-67.
Examining the Feasibility and Acceptability of an Online Yoga Class for Mood Disorders: A MoodNetwork Study.
Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD
Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. Psychol Med. 2012 Jun; 42(6):1131-49.
Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
Deckersbach T, Peters AT, Shea C, Gosai A, Stange JP, Peckham AD, Ellard KK, Otto MW, Rauch SL, Dougherty DD, Nierenberg AA
Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging. J Affect Disord. 2018 03 15; 229:342-350.
Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging.
Reilly-Harrington NA, Deckersbach T, Knauz R, Wu Y, Tran T, Eidelman P, Lund HG, Sachs G, Nierenberg AA
Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study. J Psychiatr Pract. 2007 Sep; 13(5):291-7.
Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.
Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008 Sep; 18(9):639-45.
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry. 1995 Oct; 152(10):1500-3.
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome.
Nierenberg AA, Grossbard SJ, Fava M, Rosenbaum JF
Social adjustment does not predict depressive relapse during continuation fluoxetine therapy. J Affect Disord. 1995 May 17; 34(2):73-7.
Social adjustment does not predict depressive relapse during continuation fluoxetine therapy.
Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA
STAR*D: revising conventional wisdom. CNS Drugs. 2009 Aug; 23(8):627-47.
Psychiatry and neuropsychiatry as a craft. CNS Spectr. 2009 Aug; 14(8):408-9.
Psychiatry and neuropsychiatry as a craft.
Perlis RH, Ostacher MJ, Uher R, Nierenberg AA, Casamassima F, Kansky C, Calabrese JR, Thase M, Sachs GS
Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disord. 2009 Dec; 11(8):867-75.
Stability of symptoms across major depressive episodes in bipolar disorder.
Barnett JH, Huang J, Perlis RH, Young MM, Rosenbaum JF, Nierenberg AA, Sachs G, Nimgaonkar VL, Miklowitz DJ, Smoller JW
Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011 Aug; 41(8):1593-604.
Personality and bipolar disorder: dissecting state and trait associations between mood and personality.
Hodgkin D, Volpe-Vartanian J, Merrick EL, Horgan CM, Nierenberg AA, Frank RG, Lee S
Customization in prescribing for bipolar disorder. Health Econ. 2012 Jun; 21(6):653-68.
Customization in prescribing for bipolar disorder.
Fava M, Davidson K, Alpert JE, Nierenberg AA, Worthington J, O'Sullivan R, Rosenbaum JF
Hostility changes following antidepressant treatment: relationship to stress and negative thinking. J Psychiatr Res. 1996 Nov-Dec; 30(6):459-67.
Hostility changes following antidepressant treatment: relationship to stress and negative thinking.
Nierenberg AA, Pava JA, Clancy K, Rosenbaum JF, Fava M
Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry. 1996 Oct 15; 40(8):691-6.
Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. J Clin Psychiatry. 1999 Sep; 60(9):580-3.
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
The medical consequences of the selection of an antidepressant. J Clin Psychiatry. 1992 Sep; 53 Suppl:19-24.
The medical consequences of the selection of an antidepressant.
Murphy JM, Nierenberg AA, Monson RR, Laird NM, Sobol AM, Leighton AH
Self-disparagement as feature and forerunner of depression: findings from the Stirling County Study. Compr Psychiatry. 2002 Jan-Feb; 43(1):13-21.
Self-disparagement as feature and forerunner of depression: findings from the Stirling County Study.
Montgomery SA, Bech P, Blier P, Möller HJ, Nierenberg AA, Pinder RM, Quitkin FM, Reimitz PE, Rosenbaum JF, Rush AJ, Stassen HH, Thase ME
Selecting methodologies for the evaluation of differences in time to response between antidepressants. J Clin Psychiatry. 2002 Aug; 63(8):694-9.
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE, Fava M
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. Ann Clin Psychiatry. 2002 Sep; 14(3):143-7.
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.
Perlis RH, Smoller JW, Fava M, Rosenbaum JF, Nierenberg AA, Sachs GS
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J Affect Disord. 2004 Apr; 79(1-3):291-5.
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder.
Deckersbach T, Dougherty DD, Savage C, McMurrich S, Fischman AJ, Nierenberg A, Sachs G, Rauch SL
Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder. Biol Psychiatry. 2006 Jan 15; 59(2):138-46.
Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder.
Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. CNS Spectr. 2012 Jun; 17(2):76-86.
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.
Nierenberg AA, Farabaugh AH, Alpert JE, Gordon J, Worthington JJ, Rosenbaum JF, Fava M
Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry. 2000 Sep; 157(9):1423-8.
Timing of onset of antidepressant response with fluoxetine treatment.
Petersen T, Gordon JA, Kant A, Fava M, Rosenbaum JF, Nierenberg AA
Treatment resistant depression and axis I co-morbidity. Psychol Med. 2001 Oct; 31(7):1223-9.
Treatment resistant depression and axis I co-morbidity.
Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T
Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry. 1997 Mar; 154(3):426-8.
Folate, vitamin B12, and homocysteine in major depressive disorder.